UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~June 30, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission File Number 001-35073

GEVO, INC.

(Exact name of registrant as specified in its charter)


Delaware									87-0747704
(State or other jurisdiction of incorporation or organization)									(I.R.S. Employer Identification No.)


345 Inverness Drive South, Building C, Suite 310 Englewood, CO									80112
(Address of principal executive offices)									(Zip Code)

(303) 858-8358

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share	GEVO	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐

		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May 6,~~August 5, 2022, ~~201,752,722~~235,165,951 shares of the registrant’s common stock were outstanding.

Table of Contents

GEVO, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED ~~MARCH 31,~~JUNE 30, 2022

TABLE OF CONTENTS


		Page
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	3
	Consolidated Balance Sheets as of ~~March~~ 3 1 ~~, 202~~2June 30, 2022 (unaudited) and December 31, ~~202~~12021	3
	Consolidated Statements of Operations for the three and sixmonths ended ~~March~~ 3 1 ~~, 202~~2June 30, 2022 and ~~202~~1 2021 (unaudited)	4
	Consolidated Statements of Comprehensive ~~Income (Loss)~~Loss for the three and sixmonths ended ~~March 31, 202~~2June 30, 2022 and ~~202~~1 2021 (unaudited)	5
	Consolidated Statements of Stockholders' Equity for the three and six ~~three~~ months ended ~~March 31,~~June 30, 2022 and 2021 (unaudited)	6
	Consolidated Statements of Cash Flows for the six~~three~~ months ended ~~March 31,~~June 30, 2022 and 2021 (unaudited)	78
	Notes to Consolidated Financial Statements (unaudited)	810

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2529
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3340
Item 4.	Controls and Procedures	3340

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	3441
Item 1A.	Risk Factors	3441
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3441
Item 3.	Defaults Upon Senior Securities	3441
Item 4.	Mine Safety Disclosures	3542
Item 5.	Other Information	3542
Item 6.	Exhibits	3643

	Signatures	3845

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements.

GEVO, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except share and per share amounts)


		Note	March 31, 2022		December 31, 2021			Note	As of June 30, 2022		As of December 31, 2021
Assets	Assets						Assets
Current assets	Current assets						Current assets
Cash and cash equivalents	Cash and cash equivalents		$	44,626	$	40,833	Cash and cash equivalents		$	172,984	$	40,833
Marketable securities (current)	Marketable securities (current)	5, 17	265,813		275,340		Marketable securities (current)	5	297,631		275,340
Restricted cash (current)	Restricted cash (current)	12	16,216		25,032		Restricted cash (current)	12	5,894		25,032
Accounts receivable, net	Accounts receivable, net		168		978		Accounts receivable, net		188		978
Inventories	Inventories	7	2,735		2,751		Inventories	7	2,649		2,751
Prepaid expenses and other current assets	Prepaid expenses and other current assets	4	5,861		6,857		Prepaid expenses and other current assets	4	5,275		3,607
Total current assets	Total current assets		335,419		351,791		Total current assets		484,621		348,541
Property, plant and equipment, net	Property, plant and equipment, net	8	156,896		139,141		Property, plant and equipment, net	8	176,054		139,141
Long-term marketable securities	Long-term marketable securities	5, 17	32,724		64,396		Long-term marketable securities	5	—		64,396
Long-term restricted cash	Long-term restricted cash	12	70,238		70,168		Long-term restricted cash	12	70,256		70,168
Operating right-of-use assets	Operating right-of-use assets	6	2,209		2,414		Operating right-of-use assets	6	2,098		2,414
Finance right-of-use assets	Finance right-of-use assets	6	26,887		27,297		Finance right-of-use assets	6	27,477		27,297
Intangible assets, net	Intangible assets, net	9	8,656		8,938		Intangible assets, net	9	8,364		8,938
Deposits and other assets	Deposits and other assets		5,631		2,331		Deposits and other assets		5,741		5,581
Total assets	Total assets		$	638,660	$	666,476	Total assets		$	774,611	$	666,476

Liabilities	Liabilities						Liabilities
Current liabilities	Current liabilities						Current liabilities
Accounts payable and accrued liabilities	Accounts payable and accrued liabilities	11	$	13,410	$	28,288	Accounts payable and accrued liabilities	11	$	18,750	$	28,288
Operating lease liabilities (current)	Operating lease liabilities (current)	6	416		772		Operating lease liabilities (current)	6	423		772
Finance lease liabilities (current)	Finance lease liabilities (current)	6	4,029		3,413		Finance lease liabilities (current)	6	6,293		3,413
Loans payable - other (current)	Loans payable - other (current)	12	89		158		Loans payable - other (current)	12	158		158
Total current liabilities	Total current liabilities		17,944		32,631		Total current liabilities		25,624		32,631
2021 Bonds payable (long-term)	2021 Bonds payable (long-term)	12, 17	66,669		66,486		2021 Bonds payable (long-term)	12	66,853		66,486
Loans payable - other (long-term)	Loans payable - other (long-term)	12	276		318		Loans payable - other (long-term)	12	238		318
Operating lease liabilities (long-term)	Operating lease liabilities (long-term)	6	1,838		1,902		Operating lease liabilities (long-term)	6	1,786		1,902
Finance lease liabilities (long-term)	Finance lease liabilities (long-term)	6	17,403		17,797		Finance lease liabilities (long-term)	6	16,342		17,797
Other long-term liabilities	Other long-term liabilities		95		87		Other long-term liabilities		—		87
Total liabilities	Total liabilities		104,225		119,221		Total liabilities		110,843		119,221

Stockholders' Equity	Stockholders' Equity						Stockholders' Equity
Common stock, $0.01 par value per share; 500,000,000 and 250,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 201,752,722 and 201,988,662 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.			2,019		2,020
Common stock, $0.01 par value per share; 500,000,000 and 250,000,000 shares authorized at June 30, 2022, and December 31, 2021, respectively; 235,165,951 and 201,988,662 shares issued and outstanding at June 30, 2022, and December 31, 2021, respectively.							Common stock, $0.01 par value per share; 500,000,000 and 250,000,000 shares authorized at June 30, 2022, and December 31, 2021, respectively; 235,165,951 and 201,988,662 shares issued and outstanding at June 30, 2022, and December 31, 2021, respectively.		2,353		2,020
Additional paid-in capital	Additional paid-in capital		1,107,051		1,103,224		Additional paid-in capital		1,249,880		1,103,224
Accumulated other comprehensive loss	Accumulated other comprehensive loss		(1,587)		(614)		Accumulated other comprehensive loss		(2,256)		(614)
Accumulated deficit	Accumulated deficit		(573,048)		(557,375)		Accumulated deficit		(586,209)		(557,375)
Total stockholders' equity	Total stockholders' equity		534,435		547,255		Total stockholders' equity		663,768		547,255

Total liabilities and stockholders' equity	Total liabilities and stockholders' equity		$	638,660	$	666,476	Total liabilities and stockholders' equity		$	774,611	$	666,476

See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except share and per share amounts)


		Note	Three Months Ended March 31,				Note			Three months Ended June 30,					Six Months Ended June 30,
			2022		2021				Note		2022			2021			2022			2021
Revenue and cost of goods sold	Revenue and cost of goods sold							Revenue and cost of goods sold
Ethanol sales and related products, net	Ethanol sales and related products, net	2	$	169	$	—		Ethanol sales and related products, net		2		$	71		$	—		$	240		$	—
Hydrocarbon revenue	Hydrocarbon revenue	2	63		13			Hydrocarbon revenue		2		18			346			81			359
Other revenue		2	—		80

Total revenues	Total revenues	2, 18	232		93			Total revenues		2, 18		89			346			321			359

Cost of production (including non-cash compensation expense of $0.09 million and nil, respectively)		14, 18	3,090		901
Cost of production (including stock-based compensation)								Cost of production (including stock-based compensation)		13		2,640			1,617			5,730			2,518
Depreciation and amortization	Depreciation and amortization	8, 9, 18	1,091		1,093			Depreciation and amortization		8, 9		1,088			1,177			2,179			2,270
Total cost of goods sold	Total cost of goods sold		4,181		1,994			Total cost of goods sold				3,728			2,794			7,909			4,788
Gross loss	Gross loss		(3,949)		(1,901)			Gross loss				(3,639)			(2,448)			(7,588)			(4,429)

Operating expenses	Operating expenses							Operating expenses
Research and development expense (including non-cash compensation expense of $0.1 million and $0.5 million, respectively)		14	1,192		1,378
Selling, general and administrative expense (including non-cash compensation expense of $1.4 million and $0.5 million, respectively)		14	9,367		3,814
Research and development expense (including stock-based compensation)								Research and development expense (including stock-based compensation)		13		1,966			1,332			3,158			2,710
Selling, general and administrative expense (including stock-based compensation)								Selling, general and administrative expense (including stock-based compensation)		13		9,209			4,846			18,576			8,660
Preliminary stage project costs	Preliminary stage project costs		507		2,727			Preliminary stage project costs				314			5,472			821			8,199
Other operations (including non-cash compensation expense of $0.1 million and nil, respectively)		14	589		—

Other operations (including stock-based compensation)								Other operations (including stock-based compensation)		13		601			—			1,190			—
Loss on disposal of assets								Loss on disposal of assets				—			4,954			—			4,954
Depreciation and amortization	Depreciation and amortization	8, 9, 18	351		58			Depreciation and amortization		8, 9		386			46			737			104

Total operating expenses	Total operating expenses		12,006		7,977			Total operating expenses				12,476			16,650			24,482			24,627
Loss from operations	Loss from operations	18	(15,955)		(9,878)			Loss from operations		18		(16,115)			(19,098)			(32,070)			(29,056)

Other income (expense)	Other income (expense)							Other income (expense)
(Loss) gain from change in fair value of derivative warrant liability			—		(53)
Gain (loss) from change in fair value of derivative warrant liability								Gain (loss) from change in fair value of derivative warrant liability				—			43			16			(10)
Interest expense	Interest expense	12, 18	(2)		(5)			Interest expense				(2)			(6)			(4)			(11)
Interest and dividend income		5	252		31
Investment income (loss)								Investment income (loss)		5		78			—			330			—
Gain on forgiveness of SBA loan								Gain on forgiveness of SBA loan				—			641			—			641
Other income (expense), net	Other income (expense), net		32		(152)			Other income (expense), net				2,878			167			2,894			126
Total other income (expense), net	Total other income (expense), net		282		(179)			Total other income (expense), net				2,954			845			3,236			746
Net loss	Net loss		$	(15,673)	$	(10,057)		Net loss				$	(13,161)		$	(18,253)		$	(28,834)		$	(28,310)

Net loss per share - basic and diluted	Net loss per share - basic and diluted	3	$	(0.08)	$	(0.05)		Net loss per share - basic and diluted		3		$	(0.06)		$	(0.09)		$	(0.14)		$	(0.15)

Weighted-average number of common shares outstanding - basic and diluted	Weighted-average number of common shares outstanding - basic and diluted		201,925,747		183,566,524			Weighted-average number of common shares outstanding - basic and diluted				209,809,994			198,137,420			205,889,651			190,892,223

See the accompanying Notes to the Consolidated Financial Statements.

GEVO, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE ~~INCOME (LOSS)~~LOSS

(Unaudited, in thousands)


		Note	Three Months Ended March 31,
			2022		2021			Note	Three months Ended June 30,				Six Months Ended June 30,
									2022		2021		2022		2021
Net loss	Net loss		$	(15,673)	$	(10,057)	Net loss		$	(13,161)	$	(18,253)	$	(28,834)	$	(28,310)
Other comprehensive income (loss)	Other comprehensive income (loss)						Other comprehensive income (loss)
Unrealized gain (loss) on available-for-sale securities, net of tax	Unrealized gain (loss) on available-for-sale securities, net of tax	5	(974)		—		Unrealized gain (loss) on available-for-sale securities, net of tax	5	(669)		(307)		(1,643)		(307)
Adjustment for net gain (loss) realized and included in net income, net of tax		5	1		—
Adjustment for net gain (loss) realized on available-for-sale securities and included in net income, net of tax							Adjustment for net gain (loss) realized on available-for-sale securities and included in net income, net of tax	5	—		—		1		—
Total change in other comprehensive income (loss)	Total change in other comprehensive income (loss)		(973)		—		Total change in other comprehensive income (loss)		(669)		(307)		(1,642)		(307)
Comprehensive loss	Comprehensive loss		$	(16,646)	$	(10,057)	Comprehensive loss		$	(13,830)	$	(18,560)	$	(30,476)	$	(28,617)

See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited, in thousands, except share amounts)


		For the three months ended June 30, 2022 and 2021
		Common Stock			Paid-In Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Stockholders’ Equity
	Note	Shares	Amount
Balance, March 31, 2022		201,752,722	$	2,019	$	1,107,051	$	(1,587)	$	(573,048)	$	534,435
Issuance of common stock and common stock warrants, net of issuance costs	17	33,333,336	333		138,675		—		—		139,008
Non-cash stock-based compensation	13	—	—		4,220		—		—		4,220
Issuance of common stock under stock plans, net of taxes	17	79,893	1		(66)		—		—		(65)
Other comprehensive loss		—	—		—		(669)		—		(669)
Net loss		—	—		—		—		(13,161)		(13,161)
Balance, June 30, 2022		235,165,951	$	2,353	$	1,249,880	$	(2,256)	$	(586,209)	$	663,768

Balance, March 31, 2021		198,050,449	$	1,981	$	1,101,939	$	—	$	(508,229)	$	595,691
Issuance of common stock and common stock warrants, net of issuance costs	17	—	—		(45)		—		—		(45)
Issuance of common stock upon exercise of warrants	17	3,700	—		4		—		—		4
Non-cash stock-based compensation	13	—	—		858		—		—		858
Issuance of common stock under stock plans, net of taxes	17	(89,673)	(1)		(1,824)		—		—		(1,825)
Other comprehensive loss		—	—		—		(307)		—		(307)
Net loss		—	—		—		—		(18,253)		(18,253)
Balance, June 30, 2021		197,964,476	$	1,980	$	1,100,932	$	(307)	$	(526,482)	$	576,123
See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited, in thousands, except share amounts)


		For the six months ended June 30,2022 and 2021
		Common Stock			Paid-In Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Stockholders’ Equity
	Note	Shares	Amount
Balance, December 31, 2021		201,988,662	$	2,020	$	1,103,224	$	(614)	$	(557,375)	$	547,255
Issuance of common stock and common stock warrants, net of issuance costs	17	33,333,336	333		138,675		—		—		139,008
Issuance of common stock upon exercise of warrants	17	4,677	—		3		—		—		3
Non-cash stock-based compensation	13	—	—		8,264		—		—		8,264
Issuance of common stock under stock plans, net of taxes	17	(160,724)	—		(286)		—		—		(286)
Other comprehensive loss		—	—		—		(1,642)		—		(1,642)
Net loss		—	—		—		—		(28,834)		(28,834)
Balance, June 30, 2022		235,165,951	$	2,353	$	1,249,880	$	(2,256)	$	(586,209)	$	663,768

Balance, December 31, 2020		128,138,311	$	1,282	$	643,269	$	—	$	(498,172)	$	146,379
Issuance of common stock, net of issuance costs	17	68,170,579	682		456,963		—		—		457,645
Issuance of common stock upon exercise of warrants	17	1,866,758	18		1,103		—		—		1,121
Non-cash stock-based compensation	13	—	—		1,420		—		—		1,420
Issuance of common stock under stock plans, net of taxes	17	(211,172)	(2)		(1,823)		—		—		(1,825)
Other comprehensive loss		—	—		—		(307)		—		(307)
Net loss		—	—		—		—		(28,310)		(28,310)
Balance, June 30, 2021		197,964,476	$	1,980	$	1,100,932	$	(307)	$	(526,482)	$	576,123

Note Common Stock Paid-In Capital Accumulated Other Comprehensive Loss Accumulated Deficit Stockholders’ Equity
Shares Amount
Balance, December 31, 2021 201,988,662 $ 2,020 $ 1,103,224 $ (614) $ (557,375) $ 547,255
Issuance of common stock upon exercise of warrants 10 4,677 — 3 — — 3
Non-cash stock-based compensation 14 — — 4,044 — — 4,044
Issuance of common stock under stock plans, net of taxes 14 (240,617) (1) (220) — — (221)
Other comprehensive loss — — — (973) — (973)
Net loss — — — — (15,673) (15,673)
Balance, March 31, 2022 201,752,722 $ 2,019 $ 1,107,051 $ (1,587) $ (573,048) $ 534,435
Balance, December 31, 2020 128,138,311 $ 1,282 $ 643,269 $ — $ (498,172) $ 146,379
Issuance of common stock, net of issuance costs 68,170,579 682 457,008 — — 457,690
Issuance of common stock upon exercise of warrants 10 1,863,058 18 1,099 — — 1,117
Non-cash stock-based compensation 14 — — 562 — — 562
Issuance of common stock under stock plans, net of taxes 14 (121,499) (1) 1 — — —
Net loss — — — — (10,057) (10,057)
Balance, March 31, 2021 198,050,449 $ 1,981 $ 1,101,939 $ — $ (508,229) $ 595,691

See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)


		Note	Three Months Ended March 31,					Note	Six Months Ended June 30,
			2022		2021				2022		2021
Operating Activities	Operating Activities						Operating Activities
Net loss	Net loss		$	(15,673)	$	(10,057)	Net loss		$	(28,834)	$	(28,310)
Adjustments to reconcile net loss to net cash used in operating activities:	Adjustments to reconcile net loss to net cash used in operating activities:						Adjustments to reconcile net loss to net cash used in operating activities:

Loss on disposal of assets							Loss on disposal of assets		—		4,954
(Gain) on forgiveness of SBA Loans							(Gain) on forgiveness of SBA Loans		—		(641)
Stock-based compensation	Stock-based compensation	14	4,258		925		Stock-based compensation	13	7,945		1,617
Depreciation and amortization	Depreciation and amortization	8, 9, 18	1,442		1,149		Depreciation and amortization	8, 9	2,916		2,372
Non-cash lease expense		6	139		17
Non-cash interest expense		5	1,150		—

Noncash interest expense							Noncash interest expense		2,637		—
Other noncash (income) expense							Other noncash (income) expense		352		(41)
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:						Changes in operating assets and liabilities:
Accounts receivable	Accounts receivable		810		435		Accounts receivable		790		(320)
Inventories	Inventories	7	16		39		Inventories	7	102		275
Prepaid expenses and other current assets, deposits and other assets	Prepaid expenses and other current assets, deposits and other assets	4	(2,317)		(4,273)		Prepaid expenses and other current assets, deposits and other assets	4	(1,828)		(3,142)
Accounts payable, accrued expenses and long-term liabilities	Accounts payable, accrued expenses and long-term liabilities	11, 12, 6	(2,285)		4,600		Accounts payable, accrued expenses and long-term liabilities	5, 6, 11, 12, 13	(1,194)		3,768
Net cash used in operating activities	Net cash used in operating activities		(12,460)		(7,165)		Net cash used in operating activities		(17,114)		(19,468)

Investing Activities	Investing Activities						Investing Activities
Acquisitions of property, plant and equipment	Acquisitions of property, plant and equipment	8	(31,218)		(4,630)		Acquisitions of property, plant and equipment	8	(46,165)		(14,167)
Acquisition of patent portfolio	Acquisition of patent portfolio	9	(10)		—		Acquisition of patent portfolio	9	(10)		—
Proceeds from sale and maturity of marketable securities	Proceeds from sale and maturity of marketable securities	5	71,082		—		Proceeds from sale and maturity of marketable securities	5	169,082		—

Purchase of marketable securities	Purchase of marketable securities	5	(31,993)		—		Purchase of marketable securities	5	(131,257)		(422,362)

Net cash used in investing activities	Net cash used in investing activities		7,861		(4,630)		Net cash used in investing activities		(8,350)		(436,529)

Financing Activities	Financing Activities						Financing Activities

Proceeds from issuance of 2021 Bonds							Proceeds from issuance of 2021 Bonds	12	—		68,995
Debt and equity offering costs	Debt and equity offering costs	12	—		(31,683)		Debt and equity offering costs	17	(10,993)		(34,757)
Proceeds from issuance of common stock and common stock warrants	Proceeds from issuance of common stock and common stock warrants		—		489,373		Proceeds from issuance of common stock and common stock warrants	17	150,000		487,549
Proceeds from exercise of warrants	Proceeds from exercise of warrants	10	3		1,117		Proceeds from exercise of warrants	17	3		1,119
Net settlement of common stock under stock plans	Net settlement of common stock under stock plans	14	(220)		—		Net settlement of common stock under stock plans	13	(286)		—
Payment of loans payable - other	Payment of loans payable - other	12	(103)		(27)		Payment of loans payable - other	12	(72)		(53)

Payment of finance lease liabilities	Payment of finance lease liabilities	6	(34)		—		Payment of finance lease liabilities	6	(87)		—

Net cash provided by financing activities	Net cash provided by financing activities		(354)		458,780		Net cash provided by financing activities		138,565		522,853

Net increase (decrease) in cash and cash equivalents	Net increase (decrease) in cash and cash equivalents		(4,953)		446,985		Net increase (decrease) in cash and cash equivalents		113,101		66,856
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period		136,033		78,338		Cash, cash equivalents and restricted cash at beginning of period		136,033		78,338
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period		$	131,080	$	525,323	Cash, cash equivalents and restricted cash at end of period		249,134		145,194


		Three Months Ended March 31,					Six Months Ended June 30,
Schedule of cash, cash equivalents and restricted cash	Schedule of cash, cash equivalents and restricted cash	2022		2021		Schedule of cash, cash equivalents and restricted cash	2022		2021

Cash and cash equivalents	Cash and cash equivalents	$	44,626	$	525,323	Cash and cash equivalents	$	172,984	$	17,085
Restricted cash (current)	Restricted cash (current)	16,216		—		Restricted cash (current)	5,894		57,645
Long-term restricted cash	Long-term restricted cash	70,238		—		Long-term restricted cash	70,256		70,464
Total cash, cash equivalents and restricted cash	Total cash, cash equivalents and restricted cash	$	131,080	$	525,323	Total cash, cash equivalents and restricted cash	$	249,134	$	145,194

Three Months Ended March 31,
Supplemental disclosures of cash and non-cash investing and financing transactions 2022 2021
Cash paid for interest $ 2 $ 3
Cash paid for interest capitalized to construction in progress $ 516 $ —
Non-cash interest capitalized to construction in progress $ 1 $ —
Non-cash purchase of property, plant and equipment $ 7,530 $ 999
Right-of-use asset purchased with operating lease $ — $ 1,562

See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)


	Six Months Ended June 30,
Supplemental disclosures of cash and non-cash investing and financing transactions	2022		2021
Cash paid for interest	$	757	$	9
Cash paid for interest capitalized to construction in progress	$	752	$	—
Non-cash interest capitalized to construction in progress	$	511	$	—
Non-cash purchase of property, plant and equipment	$	11,643	$	5,052
Right-of-use asset purchased with financing leases	$	834	$	27,775
Right-of-use asset purchased with operating lease	$	—	$	1,562

See the accompanying Notes to the Consolidated Financial Statements.

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

1.Nature of Business, Financial Condition and Basis of Presentation

Nature of business. Gevo, Inc. (Nasdaq: GEVO) ("Gevo" or the "Company," which, unless otherwise indicated, refers to Gevo, Inc. and its subsidiaries), a Delaware corporation founded in 2005, is a growth-oriented company with the mission of solving greenhouse gas emissions for those sectors of the transportation industry that are not amenable to electrification or hydrogen.

The Company is focused on transforming renewable energy into energy-dense liquid drop-in hydrocarbons that can be used as renewable fuels, such as sustainable aviation fuel ("SAF"), and other fuels and chemicals, with the potential to achieve a “net-zero” greenhouse gas ("GHG") footprint. The Company uses the Argonne National Laboratory’s GREET (Greenhouse gases, Regulated Emissions, and Energy use in Transportation) model (the "GREET Model") to measure, predict and verify GHG emissions across the life-cycle of its products. The “net-zero” concept means Gevo expects that by using sustainably grown feedstock (i.e., low till, no-till and dry corn cultivation), renewable and substantially decarbonized energy sources, drop-in hydrocarbon fuels can be produced that have a net-zero, full life cycle footprint measured from the capture of renewable carbon through the burning of the fuel.

Gevo's primary market focus, given current demand and growing customer interest, is SAF. The Company believes it also has commercial opportunities for other renewable hydrocarbon products, such as (i) renewable natural gas (“RNG”), (ii) hydrocarbons for gasoline blendstocks and diesel fuel, ~~(ii) ingredients for the chemical industry, such as ethylene and butenes,~~ and (iii) plastics, materials and other chemicals.

The Company believes it has the technology and know-how to convert various carbohydrate ~~feeds~~feedstocks through a fermentation process into alcohols and then transform the alcohols into renewable fuels and materials. While the Company expects its ~~first~~ major capital deployments to focus on the production of SAF, Gevo recognizes ~~that~~ there are opportunities to operate in several different markets, and it will pursue those opportunities when appropriate based on customer interest, access to capital and expected investment returns.

Gevo currently operates a wholly-owned development plant in Luverne, Minnesota (the "Luverne Facility"). The Luverne Facility was originally constructed in 1998 and is located on approximately 55 acres of land, which contains approximately 50,000 square feet of building space. Our Luverne Facility is a scale up and development site. Gevo intends to use the Luverne Facility to prove our processes, process concepts, unit operations and for other purposes in order to optimize feedstocks and the processes used for producing hydrocarbons from alcohols.

Gevo's renewable natural gas ("RNG") project in Northwest Iowa ("NW Iowa RNG") owned by Gevo NW Iowa RNG, LLC, ~~will generate~~generates RNG captured from dairy cow manure. The manure is supplied by 3 local dairies ~~located in Northwest Iowa totaling~~that have over 20,000 milking ~~cows.~~cows in total with additional milking cows expected, pursuant to agreements executed during the second quarter of 2022. Animal manure can be digested anaerobically to produce biogas, which is then upgraded to pipeline quality gas referred to as RNG. Gevo NW Iowa RNG, LLC ~~intends to sell~~then sells the RNG to the California market through an agreement with BP Canada Energy Marketing Corp. and BP Products North America Inc. (collectively, "BP"). Our dairy farm partners realize a variety of benefits including improved operational and environmental compliance options. These services facilitate long-term relationships with project hosts that may serve as a source for future projects and relationships. Gevo believes that RNG has potential to displace fossil-based natural gas used in the future production of net-zero hydrocarbon manufacturing facilities, providing the benefit of lowering the carbon intensity of hydrocarbon fuels.

In 2021, weGevo began construction on NW Iowa RNG under a self-perform project delivery format. ~~We completed most~~Most of the construction efforts were completed at the end of 2021, and in January 2022, weGevo began the process of commissioning the project. ~~NW Iowa RNG~~One of the three digesters is ~~expected to be completed within budget. All digesters~~fully operational, and the others are currently in the start-up ~~phase and are expected to reach steady production levels in the second quarter of 2022. When fully operational, NW Iowa RNG is expected to generate approximately 355,000 MMBtu of RNG per year.~~

We also operate a demonstration facility in Silsbee, Texas in partnership with South Hampton Resources, Inc. (the "South Hampton Facility"), from which the Company produces limited volumes of SAF and liquid hydrocarbon fuel.phase.

Ultimately, the Company believes that the attainment of profitable operations is dependent upon future events, including, but not limited to (i) the successful development of the Company's initial Net-Zero Project (the "Net-Zero 1 Project") ~~and~~; future projects for the production of ~~energy dense~~energy-dense liquid hydrocarbons using renewable energy and our proprietary technology; and (ii) the achievement of a level of revenues adequate to support its cost structure.

Basis of presentation. The unaudited consolidated financial statements of the Company ~~(which include the accounts of its wholly-owned subsidiaries Gevo Asset, LLC, Gevo RNG HoldCo, LLC, Gevo NW Iowa RNG, LLC, Gevo Net-Zero~~

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~HoldCo, LLC, Gevo Net-Zero 1~~, ~~LLC, and Agri-Energy, LLC (“Agri-Energy”))~~ have been prepared, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company as of, and for the ~~three~~six months ended, ~~March 31,~~June 30, 2022, and are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with the Company’s audited consolidated financial

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

statements and notes thereto included under the heading “Financial Statements and Supplementary Data” in Part II, Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The financial statements at December 31, 2021, have been derived from the audited financial statements as of that date. For further information, refer to our audited financial statements and notes thereto included for the year ended December 31, 2021 (the "2021 Annual Report").

Reclassifications. The Company reclassified certain prior period amounts to conform to the current period presentation, including the categorization of depreciation and amortization on the Consolidated Statements of Operations. These reclassifications had no impact on total revenues, total cost of goods sold, total operating expenses, net loss or stockholders' equity for any period.

2.Revenues from Contracts with Customers and Other Revenues

The Company's limited revenues are derived from 2its development-scale ~~plants: (i) the South Hampton Facility and (ii)~~plant, the Luverne Facility. These revenues are promotional in nature and from customer contracts for ethanol sales and related products and hydrocarbon revenues, which include SAF, isooctene, and isooctane. These products are sold mostly on a free-on-board, shipping point basis (recognized at a point in time), are independent transactions, do not provide post-sale support or promises to deliver future goods, and are single performance obligations. Historically, grant revenues consisted of governmental and cooperative research grants, while other revenue includes consulting services and short-term leases for certain storage facilities at the Luverne Facility. For the quarters ended March 31, 2022 and 2021, there were no ~~variable revenues and as of March 31, 2022 and December 31, 2021, there were~~ no remaining unfulfilled or partially fulfilled performance obligations. The Company does not offer explicit or implicit price concessions, so it records the revenue and trade receivables at 100% of the transaction price. Since all amounts are provided and due in less than one year, the Company elects to not record a financing component.

3.Net loss Per Share

Basic net loss per share is calculated based on the weighted average number of common shares outstanding for the period. Diluted net loss per share is calculated based on the assumption that stock options and other dilutive securities outstanding, which have an exercise price less than the average market price of the Company's common shares during the period, would have been exercised on the later of the beginning of the period or the date granted and that the funds obtained from the exercise were used to purchase common shares at the average market price during the period. None of the Company's stock options or other dilutive securities are considered to be dilutive in periods with net losses.

The effect of the Company’s dilutive securities is calculated using the treasury stock method and only those instruments that result in a reduction in net income per common share are included in the calculation. Diluted net loss per share for the ~~three~~six months ended ~~March 31,~~June 30, 2022, and 2021 excluded ~~1,751,170~~22,464,715 and ~~220,099,~~202,356, respectively, of common stock equivalents because the effect of their inclusion would be anti-dilutive or would decrease the reported net loss per share.

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

Basic and diluted net loss per share is calculated as follows (net loss in thousands):

Three Months Ended March 31,
2022 2021
Net loss $ (15,673) $ (10,057)
Basic and diluted weighted-average shares outstanding 201,925,747 183,566,524
Basic and diluted net loss per share $ (0.08) $ (0.05)


	Three months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Net loss	$	(13,161)	$	(18,253)	$	(28,834)	$	(28,310)
Basic weighted-average shares outstanding	209,809,994		198,137,420		205,889,651		190,892,223
Basic net loss per share	$	(0.06)	$	(0.09)	$	(0.14)	$	(0.15)

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

4.Prepaid and Other Current Assets

The following table sets forth the components of the Company’s prepaid and other current assets (in thousands): as of:


		March 31, 2022		December 31, 2021			June 30, 2022		December 31, 2021
Prepaid insurance	Prepaid insurance	$	397	$	805	Prepaid insurance	$	1,543	$	805
Interest receivable	Interest receivable	1,252		1,530		Interest receivable	1,022		1,530
Exclusivity fees		—		3,250
Prepaid engineering		2,275		409
Prepaid engineering (1)						Prepaid engineering (1)	900		409
Tax refunds						Tax refunds	401		—
Prepaid other	Prepaid other	1,937		863		Prepaid other	1,409		863
Total Prepaid and other current assets	Total Prepaid and other current assets	$	5,861	$	6,857	Total Prepaid and other current assets	$	5,275	$	3,607

~~The $3.3 million of prepaid fees above are exclusivity fees and are reported in Deposits and other assets in~~

(1)Related to the ~~Consolidated Balance Sheets (Note 13) as of March 31, 2022.~~Net-Zero 1 Project development.

5.Marketable Securities

The Company's investments in marketable securities are stated at fair value and are available-for-sale. The following table summarizes the Company's investments in marketable securities (in thousands): as of:


			Available-for-Sale Securities at March 31, 2022								June 30, 2022
		Maturity	Amortized Cost Basis		Gross Unrealized Losses		Fair Value			Maturity	Amortized Cost Basis		Gross Unrealized Losses		Fair Value

Short-term marketable securities	Short-term marketable securities								Short-term marketable securities
U.S. Treasury notes	U.S. Treasury notes	Within one year	$	188,665	$	(527)	$	188,138	U.S. Treasury notes	Within one year	$	162,238	$	(800)	$	161,438
U.S. Government-sponsored enterprise securities	U.S. Government-sponsored enterprise securities	Within one year	78,375		(700)		77,675		U.S. Government-sponsored enterprise securities	Within one year	137,649		(1,456)		136,193
Total short-term marketable securities	Total short-term marketable securities		$	267,040	$	(1,227)	$	265,813	Total short-term marketable securities		$	299,887	$	(2,256)	$	297,631

Long-term marketable securities
U.S Treasury notes		Within two years	$	11,040	$	(72)	$	10,968
U.S. Government-sponsored enterprise securities		Within two years	22,044		(288)		21,756
Total long-term marketable securities			$	33,084	$	(360)	$	32,724

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~


			Available-for-Sale Securities at December 31, 2021								December 31, 2021
		Maturity	Amortized Cost Basis		Gross Unrealized Losses		Fair Value			Maturity	Amortized Cost Basis		Gross Unrealized Losses		Fair Value

Short-term marketable securities	Short-term marketable securities								Short-term marketable securities
U.S. Treasury notes	U.S. Treasury notes	Within one year	$	226,136	$	(344)	$	225,792	U.S. Treasury notes	Within one year	$	226,136	$	(344)	$	225,792
U.S. Government-sponsored enterprise securities	U.S. Government-sponsored enterprise securities	Within one year	49,618		(70)		49,548		U.S. Government-sponsored enterprise securities	Within one year	49,618		(70)		49,548
Total short-term marketable securities	Total short-term marketable securities		$	275,754	$	(414)	$	275,340	Total short-term marketable securities		$	275,754	$	(414)	$	275,340

Long-term marketable securities	Long-term marketable securities								Long-term marketable securities
U.S Treasury notes		Within two years	$	—	$	—	$	—
U.S. Government-sponsored enterprise securities	U.S. Government-sponsored enterprise securities	Within two years	64,596		(200)		64,396		U.S. Government-sponsored enterprise securities	Within two years	64,596		(200)		64,396
Total long-term marketable securities	Total long-term marketable securities		$	64,596	$	(200)	$	64,396	Total long-term marketable securities		$	64,596	$	(200)	$	64,396

The cost of securities sold is based upon the specific identification method. Interest receivable related to the marketable securities of ~~$1.3~~$1.0 million was included within ~~prepaid~~"Prepaid expenses and other current ~~assets~~assets" on the ~~accompanying~~ Consolidated Balance Sheets as of ~~March 31,~~June 30, 2022.

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Interest income from marketable securities totaled ~~$1.6~~$1.2 million and $2.7 million for the three and six months ended ~~March 31,~~June 30, 2022, (respectively and nil for the three and six months ended ~~March 31, 2021) and~~June 30, 2021. Interest income from marketable securities is included in ~~"Interest and dividend income"~~"Investment income (loss)" in the Consolidated Statements of Operations.

Future maturities of the Company's marketable securities are ~~$207.0~~$131.4 million in 2022 and ~~$91.5~~$168.6 million in 2023.

6.Leases, Right-of-Use Assets and Related Liabilities

The Company is party to an operating lease contract for the Company’s office and research facility in Englewood, Colorado, ~~that~~which expires in January 2029. The lease contains an option to extend the lease which management does not reasonably expect to exercise, so it is not included in the length of the term. The Company also has one production line piece of equipment with an operating lease that expires in 2024. As of ~~March 31,~~June 30, 2022, right-of-use assets under operating leases totaling ~~$2.2~~$2.1 million are included in "Operating right-of use assets," and related lease liabilities totaling ~~$2.3~~$2.2 million ($0.4 million in current and $1.8 million in long-term) are included in the Consolidated Balance Sheets.

The Company also has 4 finance leases for land under arrangements related to NW Iowa RNG. Under these contracts, the Company leases land from dairy farmers on which it has built 3 anaerobic digesters, and related equipment and pipelines to condition raw biogas from cow manure provided by the farmers. The partially conditioned biogas ~~will be~~is transported from the 3 digester sites to a central gas upgrade system located at the fourth site that will upgrade the biogas to pipeline quality RNG for sale. These leases expire at various dates between 2031 and 2050. The Company amended one of its leases in June 2022, which the Company treated as an existing lease modification due to an increase in the price per unit, resulting in an increase of the lease liability and right-of-use-asset by $0.8 million.

Since the Company ~~adopted~~elected the practical expedient to combine lease and non-lease components, all amounts paid to the ~~lessor~~lessors under these arrangements for cow manure and non-lease services are classified as lease payments and are included in the calculation of the right-of-use assets and lease liabilities. This results in significantly higher right-of-use assets and lease liabilities than if the Company did not elect this practical expedient. ~~The Company also has one office equipment finance lease, which expires in 2025.~~ As of ~~March 31,~~June 30, 2022, right-of-use assets under finance leases totaling ~~$26.9~~$27.5 million are included in "Finance right-of-use assets," and related lease liabilities totaling ~~$21.4~~$22.6 million ~~($4.0 million in current and $17.4 million in long-term)~~ are included in the Consolidated Balance Sheets.

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

The following ~~table presents~~four tables present the (a) costs by lease category, ~~and~~ (b) other quantitative information, ~~relating~~and (c) future minimum payments under non-cancelable financing and operating leases as they relate to the Company’s leases (in thousands):, except for weighted averages:


		Three Months Ended March 31,					Three months Ended June 30,
		2022		2021			2022		2021
Lease Cost
Finance lease cost:	Finance lease cost:					Finance lease cost:
Amortization of right-of-use assets (1)	Amortization of right-of-use assets (1)	$	464	$	—	Amortization of right-of-use assets (1)	$	488	$	447
Interest on lease liabilities (1)	Interest on lease liabilities (1)	262		11		Interest on lease liabilities (1)	251		316
Operating lease cost	Operating lease cost	139		61		Operating lease cost	139		67
Short-term lease cost	Short-term lease cost	379		132		Short-term lease cost	572		495
Variable lease cost (2)	Variable lease cost (2)	115		39		Variable lease cost (2)	73		31

Total lease cost	Total lease cost	$	1,359	$	243	Total lease cost	$	1,523	$	1,356

~~(1)~~1.~~$0.6~~Amortization and interest on finance lease liabilities of $0.7 million and ~~$0.4~~$0.8 million ~~of amortization and interest expense~~was capitalized as construction-in-progress for the three months ended ~~March 31,~~June 30, 2022, and June 30, 2021, ~~respectively, were capitalized as part of construction in progress, for related finance lease liabilities of $23.0 million and $0.6 million,~~ respectively. The accumulated capitalized amounts of $3.0 million are included in "Property, plant and equipment, net" in the Consolidated Balance Sheets as the related NW Iowa RNG facilities were still under construction on March 31, 2022. Since these leases include approximately 75% fuel supplies, when the RNG facilities reach 60% production (expected in the second or third quarter of 2022), these capitalized amounts will be moved to inventory, and as units are sold they will be expensed through cost of goods sold.

~~(2)~~2.Represents amounts incurred in excess of minimum payments, including payments for common area expenses under our office and research facility lease, and additional amounts due under our NW Iowa RNG leases based on the number of cows maintained by the owners above the minimum required by the contracts of the respective facilities.

Table of Contents

Three Months Ended March 31,
2022 2021
Other Information

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases $ 16 $ 6
Operating cash flows from operating leases $ 456 $ 61
Finance cash flows from finance leases $ 34 $ 7
Right-of-use asset obtained in exchange for new finance lease liabilities $ — $ —
Right-of-use asset obtained in exchange for new operating lease liabilities $ — $ 1,562
Weighted-average remaining lease term, finance lease (months) 215 221
Weighted-average remaining lease term, operating leases (months) 71 94
Weighted-average discount rate - finance leases (1) 5% 13%
Weighted-average discount rate - operating leases (1) 5% 5%
GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)


	Six Months Ended June 30,
	2022		2021
Finance lease cost:
Amortization of right-of use assets (1)	$	949	$	458
Interest on lease liabilities (1)	525		316
Operating lease cost	277		67
Short-Term lease cost	1,449		495
Variable lease cost (2)	951		31
Total lease cost	$	4,151	$	1,367

1.$1.5 million and $0.8 million of amortization and interest expense for the six months ended June 30, 2022, and 2021, respectively, were capitalized as part of construction in progress. The accumulated capitalized amounts of $3.7 million is included in "Property, plant and equipment, net" in the Consolidated Balance Sheets as the related NW Iowa RNG facilities were still under construction on June 30, 2022.

2.Represents amounts incurred in excess of minimum payments, including payments for common area expenses under our office and research facility lease, and additional amounts due under our NW Iowa RNG leases based on the number of cows maintained by the owners above the minimum required by the contracts of the respective facilities.


	Six Months Ended June 30,
	2022		2021
Other Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	$	241	$	321
Operating cash flows from operating leases	$	359	$	128
Finance cash flows from finance leases	$	87	$	3,046
Right-of-use asset obtained in exchange for new finance lease liabilities	$	834	$	27,775
Right-of-use asset obtained in exchange for new operating lease liabilities	$	—	$	1,562
Weighted-average remaining lease term, finance lease (months)	216		218
Weighted-average remaining lease term, operating leases (months)	68		91
Weighted-average discount rate - finance leases (1)	10%		5%
Weighted-average discount rate - operating leases (1)	5%		5%

(1)Our leases do not provide an implicit interest rate, we calculate the lease liability at lease commencement as the present value of unpaid lease payments using our estimated incremental borrowing rate. The ~~discount~~incremental borrowing rate ~~used for operating~~represents the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and ~~finance leases~~ is determined using a portfolio approach based on information available at the ~~Company's implicit borrowing rate ("IBR"). The Company estimated~~commencement date of the ~~IBR based on collateralized borrowings for similar terms and payments.~~lease.

1214

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

~~The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2022~~ (~~in thousands):~~


Year ending December 31,	Year ending December 31,	Operating Leases		Finance Leases		Year ending December 31,	Operating Leases		Finance Leases

2022 (remaining)	2022 (remaining)	$	447	$	2,204	2022 (remaining)	$	376	$	7,282
2023	2023	528		1,713		2023	529		1,554
2024	2024	305		1,729		2024	306		2,730
2025	2025	315		1,743		2025	315		1,744
2026	2026	324		1,781		2026	325		1,760
2027 and thereafter	2027 and thereafter	706		22,130		2027 and thereafter	707		29,583
Total	Total	2,625		31,300		Total	2,558		44,653
Less: Amounts representing present value discounts	Less: Amounts representing present value discounts	371		9,868		Less: Amounts representing present value discounts	349		22,018

Total lease liabilities	Total lease liabilities	2,254		21,432		Total lease liabilities	2,209		22,635
Less: current portion	Less: current portion	416		4,029		Less: current portion	423		6,293
Long-term portion	Long-term portion	$	1,838	$	17,403	Long-term portion	$	1,786	$	16,342

7.Inventories

The following table sets forth the components of the Company’s inventory balances (in thousands): as of:


		March 31, 2022		December 31, 2021			June 30, 2022		December 31, 2021
Raw materials
Raw materials:						Raw materials:
Corn	Corn	$	223	$	301	Corn	$	179	$	301
Enzymes and other inputs	Enzymes and other inputs	108		183		Enzymes and other inputs	57		186
Nutrients		2		3
Palladium	Palladium	203		265		Palladium	203		265
Finished goods
SAF, Isooctane and Isooctene		501		335
Finished goods:						Finished goods:
SAF, Isooctane, Isooctene and other						SAF, Isooctane, Isooctene and other	504		335
Isobutanol	Isobutanol	181		223		Isobutanol	124		223
Ethanol	Ethanol	82		96		Ethanol	146		96
Work in process
Work in process:						Work in process:
Agri-Energy	Agri-Energy	84		83		Agri-Energy	51		83
Gevo	Gevo	51		—		Gevo	71		—
Spare parts	Spare parts	1,300		1,262		Spare parts	1,314		1,262

Total inventories	Total inventories	$	2,735	$	2,751	Total inventories	$	2,649	$	2,751

Work in process inventory includes unfinished SAF, isooctane, and isooctene inventory.

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, the Company adjusted its finished goods and work in process inventory to net realizable value and recorded a ~~$2.9~~$0.8 million loss in cost of goods sold. There were no net realizable losses recorded during the ~~three~~six months ended ~~March 31,~~June 30, 2021, as the Luverne Facility was temporarily shut down due to the COVID-19 pandemic.

1315

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

8.Property, Plant and Equipment

The following table sets forth the Company’s property, plant and equipment by classification (in thousands): as of:

Useful Life (in years) March 31, 2022 December 31, 2021
Luverne Facility retrofit asset 20 $ 70,820 $ 70,820
Plant machinery and equipment 10 17,949 17,949
Site improvements 10 7,157 7,157
Lab equipment, furniture and fixtures and vehicles 5 6,813 6,811
Demonstration plant 2 3,597 3,597
Buildings 10 2,543 2,543
Leasehold improvements, pilot plant, land and support equipment 2 to 7 2,841 2,802
Computer, office equipment and software 3 to 6 2,338 2,332
Construction in progress — 107,848 88,989
Total property, plant and equipment 221,906 203,000
Less accumulated depreciation and amortization (65,010) (63,859)
Property, plant and equipment, net $ 156,896 $ 139,141


	Useful Life (in years)			June 30, 2022		December 31, 2021
Land				$	410	$	410
Plant facilities and infrastructure	5	to	20	84,117		84,117
Machinery and equipment	5	to	10	25,416		25,369
Furniture and office equipment	3	to	7	2,606		2,550
Software	3	to	6	1,621		1,564
Construction in progress				128,080		88,990
Total property, plant and equipment				242,250		203,000
Less accumulated depreciation and amortization				(66,196)		(63,859)
Property, plant and equipment, net				$	176,054	$	139,141

The Company recorded depreciation expense of $1.2 million and ~~amortization expense related to property, plant~~$2.3 million for the three and ~~equipment~~six months ended June 30, 2022, respectively, as compared with $1.2 million and ~~intangible assets as follows (in thousands):~~$2.4 million for the same periods ended June 30, 2021.

Three Months Ended March 31,
2022 2021
Depreciation:
Cost of goods sold $ 1,086 $ 1,088
Operating expenses 65 56
Patent amortization:
Cost of goods sold 5 5
Operating expenses 286 —
Total depreciation and amortization $ 1,442 $ 1,149

At June 30, 2022, construction in progress included accruals of $11.5 million.

Construction in progress includes ~~$0.6~~$0.8 million for Gevo, ~~$13.1~~$13.4 million for our subsidiary, Agri-Energy, ~~$67.4~~LLC ("Agri-Energy") $75.5 million for NW Iowa RNG and ~~$26.8~~$38.4 million for the Net-Zero 1 Project at ~~March 31,~~June 30, 2022. Construction in progress includes $0.4 million for Gevo, $9.1 million for Agri-Energy, $56.9 million for NW Iowa RNG and $22.5 million for the Net-Zero 1 Project at December 31, 2021. Construction in progress is not subject to depreciation until the assets are placed into service.

Borrowing costs. Borrowing costs directly attributable to acquisition and construction of an asset are capitalized until it is completed and ready for its intended use, and thereafter are recognized in profit or loss for the current period. The Company capitalized ~~$0.5~~$0.8 million and nil of interest expense for the ~~three~~six months ended ~~March 31,~~June 30, 2022, and ~~March 31,~~June 30, 2021, respectively.

9.Intangible Assets

Intangible assets consist of patents, which management evaluates to determine whether they (i) support current ~~products;~~products, (ii) support planned research and development, or (iii) prevent others from competing with Gevo's products.

The following table sets forth the Company’s identifiable intangible assets by classification (in thousands) as of:


	June 30, 2022
	Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, Net		Weighted-Average Useful Life (Years)
Patents	$	4,580	$	(664)	$	3,916	7.3
Defensive assets	4,900		(452)		4,448		8.4
Identifiable intangible assets	$	9,480	$	(1,116)	$	8,364	7.9

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)


	December 31, 2021
	Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, Net		Weighted-Average Useful Life (Years)
Patents	$	4,575	$	(368)	$	4,207	7.3
Defensive assets	4,895		(164)		4,731		8.4
Identifiable intangible assets	$	9,470	$	(532)	$	8,938	7.9

The ~~following table sets forth~~Company recorded amortization expense of $0.3 million and $0.6 million for the ~~Company’s identifiable intangible assets by classification (in thousands):~~three and six months ended June 30, 2022, respectively, as compared with nil and nil for the same periods ended June 30, 2021.

March 31, 2022
Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years)
Finite-lived intangible assets:
Patents $ 4,580 $ (516) $ 4,064 7.3
Defensive assets 4,900 (308) 4,592 8.4
Identifiable intangible assets $ 9,480 $ (824) $ 8,656 7.9

December 31, 2021
Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years)
Finite-lived intangible assets:
Patents $ 4,575 $ (368) $ 4,207 7.3
Defensive assets 4,895 (164) 4,731 8.4
Identifiable intangible assets $ 9,470 $ (532) $ 8,938 7.9

The following table details the estimated amortization of identifiable intangible assets as of ~~March 31,~~June 30, 2022 (in thousands):

Year ending December 31, Patents Defensive Assets Total
2022 (remaining) $ 452 $ 442 $ 894
2023 599 586 1,185
2024 601 588 1,189
2025 599 586 1,185
2026 585 586 1,171
2027 and thereafter 1,228 1,804 3,032
Total $ 4,064 $ 4,592 $ 8,656

~~See Note 8 for the amortization of intangible assets for the three months endedMarch 31, 2022and March 31, 2021~~.


Year ending December 31,	Patents		Defensive Assets		Total
2022 (remaining)	$	304	$	297	$	601
2023	599		586		1,185
2024	601		588		1,189
2025	599		586		1,185
2026	585		586		1,171
2027 and thereafter	1,228		1,805		3,033
Total	$	3,916	$	4,448	$	8,364

10.~~Warrants~~Deposits and Other Assets

~~On February 17, 2022, the Series K warrants expired with 7,126 unexercised warrants.~~

The following table sets forth ~~information pertaining to shares issued upon~~ the ~~exercise~~components of ~~warrants:~~the Company's Deposits and other assets (in thousands) as of:

Issuance Date Expiration Date Exercise Price as of March 31, 2022 Shares Underlying Warrants on Issuance Date Shares Issued upon Warrant Exercises as of March 31, 2022 Shares Underlying Warrants Outstanding as of March 31, 2022
Series 2020-A Warrants (1) 7/6/2020 7/6/2025 $ 0.60 30,000,000 29,914,069 85,931


	June 30, 2022		December 31, 2021
Deposits (1)	$	991	$	831
Equity interest (2)	1,500		1,500
Exclusivity fees (3)	3,250		3,250
Total Deposits and Other Assets	$	5,741	$	5,581

(1) Deposits for legal services and product for the Net-Zero 1 Project.

(2) The Company directly holds 4.6% interest of the Series ~~2020-A Warrants are equity-classified warrants.~~A Preferred Stock in Juhl Clean Energy Assets, Inc. ("Juhl"), which is not a publicly listed entity with readily determinable fair value. The Company therefore measures the securities at cost, which is deemed to be the value indicated by the last observable transaction in Juhl's stock, subject to impairment. The equity interest in Juhl is also pledged as collateral against two future obligations to Rock County Wind Fuel, LLC ("RCWF"), a Juhl subsidiary, see Footnote 15, Commitments and Contingencies, for additional information.

(3) Axens North America, Inc. ("Axens") will provide certain alcohol-to-SAF services exclusively to the Company which may be offset against future license fees subject to the delivery of a process design package.

1517

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

~~During the three months ended March 31, 2022~~, ~~common stock was issued as a result of the exercise of warrants as shown below (dollars in thousands):~~

Common Stock Issued Proceeds
Series 2020-A Warrants 4,677 $ 3

11.Accounts Payable and Accrued Liabilities

The following table sets forth the components of the Company's accounts payable and accrued liabilities (in thousands): as of:

March 31, 2022 December 31, 2021
Accounts payable - trade $ 1,399 $ 4,868
NW Iowa RNG accrued project costs 2,902 11,000
Accrued employee compensation 3,294 4,678
Net-Zero 1 accrued project costs 2,778 5,010
Other accrued liabilities 3,037 2,732
Total accounts payable and accrued liabilities $ 13,410 $ 28,288


	June 30, 2022		December 31, 2021
Accounts payable	$	3,378	$	4,830
Accrued liabilities	11,519		18,345
Accrued payroll and related benefits	3,454		4,678
Other accrued liabilities	399		435
Total accounts payable and accrued liabilities	$	18,750	$	28,288

12.Debt

2021 Bond Issuance

On April 15, 2021, on behalf of Gevo NW Iowa RNG, LLC, the Iowa Finance Authority ("the "Authority") issued $68,155,000 of its non-recourse Solid Waste Facility Revenue Bonds (Gevo NW Iowa RNG, LLC Renewable Natural Gas Project), Series 2021 (Green Bonds) (the "2021 Bonds") for NW Iowa RNG. The bond proceeds are being used as a source of construction financing alongside equity from the Company. The bonds were issued under a Trust Indenture dated ~~as of~~ April 1, 2021 (the "Indenture") between the Authority and Citibank, N.A. as trustee (the "Trustee"). The 2021 Bonds mature April 1, 2042. ~~They~~The bonds initially bear interest at 1.50% per annum during the Initial Term Rate Period, (as defined in the Indenture), payable semi-annually on January 1 and July 1 of each year. The effective interest rate is 1%. The bonds are supported by a $71.2 million irrevocable direct pay letter of credit (the "Letter of Credit")~~, which~~ with a 1/2% annual fee, paid quarterly. The Letter of Credit expires April 4, 2024 (unless terminated earlier), and was issued by Citibank N.A. The Trustee ~~will~~can draw sufficient amounts on the Letter of Credit to pay the principal and interest until the first mandatory tender date of April 1, 2024. The bonds are callable and re-marketable on or after October 1, 2022. If the bonds have not been called and re-marketed by the first mandatory tender date, the Trustee may draw on the Letter of Credit to repay the bonds in their entirety at the purchase price. Gevo deposited $71.2 million with ~~Citibank, N.A.~~the Trustee as restricted cash to secure any amounts drawn under the Letter of Credit. As of ~~March 31,~~June 30, 2022, no amounts have been drawn under the Letter of Credit.

Gevo anticipates re-marketing the 2021 Bonds in the fall of 2022 under revised terms that will include a long-term maturity date and be non-recourse to Gevo. Upon a successful remarketing, Gevo anticipates that the Letter of Credit, the associated reimbursement agreement and the associated pledge of cash will be terminated, with a concurrent release of the restricted cash securing the Letter of Credit.

The 2021 Bonds were issued at a premium of $0.8 million and debt issuance costs were $3.0 million. The bond debt is classified as long-term debt and is presented net of the premium and issuance costs, which are being amortized over the life of the bonds using the interest method. As of ~~March 31,~~June 30, 2022, the premium balance and the debt issuance cost net of amortization were ~~$0.6~~$0.5 million and ~~$2.1~~$1.9 million, respectively.

Restricted cash and cash equivalents. The Company’s restricted cash and ~~restricted~~ cash equivalents consists of unused proceeds from the issuance of the 2021 Bonds and are restricted for the purpose of constructing NW Iowa RNG projects as well as amounts pledged and assigned to ~~Citibank, N.A.~~the Trustee in its capacity as provider of the Letter of Credit as collateral for the reimbursement obligations of Gevo.

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

The proceeds from issuance of the 2021 Bonds are maintained by the Trustee under the Indenture and are released to the Company only to pay costs of the construction of NW Iowa RNG. The Company has used ~~$53.0~~$63.8 million for the project. As of ~~March 31,~~June 30, 2022, unused bond proceeds of ~~$15.2~~$5 million are included in restricted cash and classified as current since the proceeds will be distributed within 12 months. ~~We expect all construction invoices will be received and paid, and the remaining unused bond proceeds will be released to reimburse Gevo by the end of the second quarter of 2022.~~

As of ~~March 31,~~June 30, 2022, $71.2 million is held in restricted cash as collateral for the Letter of Credit. The Company is entitled to receive interest income on the restricted cash.

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The restricted cash held by the Trustee is made up of the following (in thousands)~~. Numbers~~, which amounts are ~~stated~~reflected since inception and as of, ~~March 31, 2022:~~as applicable:


	~~March 31,~~June 30, 2022

Bond proceeds	$	68,995
Disbursement of funds	~~(53,085)~~(63,809)
Interest paid on bonds	(727)
~~Interest income~~Funds transferred to current restricted assets (to pay interest on bonds)	11413
Interest income	—
Total restricted bond cash held by Trustee	4,872
Restricted cash for bond collateral held by Trustee	71,278
Total restricted cash held by Trustee	~~15,194~~
~~Total restricted cash for collateral~~	~~71,260~~

~~Total restricted cash and restricted cash equivalents~~	~~86,454~~76,150
Current ~~portion~~restricted cash held by Trustee	~~(16,216)~~(5,894)

~~Total~~Long-term restricted cash held by Trustee	$	~~70,238~~70,256

Loans Payable - Other

The equipment loans are secured by the related equipment.

In April 2020, the Company and Agri-Energy each entered into a loan agreement with Live Oak Banking Company, pursuant to which the Company and Agri-Energy obtained loans from the Small Business Administration's Paycheck Protection Program (“SBA PPP”) totaling $1.0 million in the aggregate (the "SBA Loans").

OnIn April ~~15,~~ 2021, the Small Business Administration forgave the entire balance of $0.5 million of the Company's and $0.1 million of Agri-Energy's loans and accrued interest obtained through the SBA PPP. The remaining SBA Loan for Agri-Energy totals $0.3 million, bears interest at 1.0% per annum and matures in April 2025. Monthly payments of $8,230, including interest, began on June 5, 2021, and are payable through April 2025.

The summary of the ~~2021 Bonds and Loans payable - other~~Company's long-term debt is as follows (in thousands) as of:


	Interest Rate			Maturity Date			June 30, 2022		December 31, 2021
2021 Bonds	1.5%			January 2042			$	66,853	$	66,486
SBA Loans	1.0%			April 2025			272		320
Equipment	4%	to	5%	February 2022	to	December 2024	124		156
Total loans payable - other							67,249		66,962
Less current portion							(158)		(158)
Long-term portion							$	67,091	$	66,804

Future principal payments for the Company's long-term debt are as follows (in thousands):

Interest Rate Maturity Date March 31, 2022 December 31, 2021
2021 Bonds 1.5% January 2042 $ 66,669 $ 66,486
SBA Loans 1.0% April 2025 296 320
Equipment 4% to 5% February 2022 to December 2024 70 156
Total loans payable - other 67,035 66,962
Less current portion (89) (158)
Long-term portion $ 66,946 $ 66,804


Year Ending December 31,	Total Debt
2022 (remaining)	$	78
2023	159
2024	66,983
2025	29
2026	—
Total loans payable - other	$	67,249

1719

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

~~Future principal payments for the Company's long-term debt are as follows (in thousands):~~

Year Ending December 31,
2022 (remaining) $ 48
2023 159
2024 66,799
2025 29
2026 —
$ 67,035

13.~~Deposits and Other Assets~~

~~Deposits and other assets include the following:~~

March 31, 2022 December 31, 2021
Deposits (1) $ 881 $ 831
Investment in Juhl (2) 1,500 1,500
Exclusivity fees (3) 3,250 —
Total Deposits and Other Assets $ 5,631 $ 2,331

~~(1) Deposits for legal services and for product for Net-Zero 1.~~

~~(2) Investment in Juhl's future wind farms.~~

~~(3) Axens North America, Inc. ("Axens") will provide certain alcohol-to-SAF services exclusively to the Company which may be offset against future license fees.~~

~~14.~~Stock-Based Compensation

Equity incentive plans. In February 2011, the Company’s stockholders approved the Gevo, Inc. 2010 Stock Incentive Plan (as amended and restated to date, the "2010 Plan"), and the Employee Stock Purchase Plan (the "ESPP").

The 2010 Plan ~~provided~~provides for the grant of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units and other equity awards to employees and directors of the Company. On June 9, 2021, ~~with~~upon approval of stockholders at the 2021 Annual Meeting of Stockholders, the 2010 Plan was amended and restated, which increased the number of shares of common stock reserved for issuance under the 2010 Plan to ~~a total of 22,980,074. At March 31,~~22,980,074 shares. On June 30, 2022, ~~7,717,026 shares~~7,645,467 shares remained available for awards under the 2010 Plan.

Restricted common stock and non-qualified stock option activity during the ~~three~~six months ended ~~March 31,~~June 30, 2022, consisted of the following:

Period
Total Number of Restricted Shares Issued

Total Number of Non-qualified Stock Options Granted Vesting Periods Years
January 1, 2022 to March 31, 2022 (340,502) (1) — N/A
Total (340,502) —


Period	Total Number of Restricted Shares Issued	Total Number of Non-qualified Stock Options Granted	Vesting Periods Years
January 1, 2022 to March 31, 2022 (1)	(340,502)	—	N/A
April 1, 2022 to June 30, 2022 (1)	(165,174)	—	N/A
Total	(505,676)	—

(1)Includes shares of common stock cancelled ~~related~~in relation to ~~the~~ unvested restricted stock awards.

~~ESPP~~Employee Stock Purchase Plan ("ESPP"). The offering periods for the ESPP are from January 1 to June 30 and from July 1 to December 31 of each calendar year. The Company has reserved 190 shares of common stock for issuance under the ESPP, of which 190 shares as of ~~March 31,~~June 30, 2022, are available for future issuance. The purchase price of the common stock under the ESPP is 85% of

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~the~~ lower ofthan the fair market value of a share of common stock on the first or last day of the purchase period. There were no purchases of common stock under the ESPP during the ~~three~~six months ended ~~March 31,~~June 30, 2022, or 2021.

Stock Appreciation Rights. The Company granted 67,739 stock appreciation rights valued at an aggregate of $0.1 million on the respective dates of grant during the year ended December 31, 2018. The vesting period for stock appreciation rights granted are based upon a service period. The stock appreciation rights have the potential to be cash settled in the event there are insufficient shares available from the 2010 Plan and are therefore classified as a liability and remeasured at each reporting period based on the price of the Company's common stock.

Stock-based compensation expense. The Company records stock-based compensation expense during the requisite service period for share-based payment awards granted to employees and non-employees.

Our stock-based compensation is classified as either an equity award or a liability award in accordance with generally accepted accounting principles. The fair value of an equity-classified award is determined at the grant date and is amortized on a straight-line basis over the vesting life of the award. The fair-value of a liability-classified award is determined on a quarterly basis through the final vesting date and is amortized based on the current fair value of the award and the percentage of vesting period incurred to date.

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The following table sets forth the Company’s stock-based compensation expense for the periods indicated (in thousands):

Three Months Ended March 31,
2022 2021
Equity Classified Awards
Stock options
Cost of goods sold $ 85 $ —
Research and development 51 —
Selling, general and administrative 1,444 —
Preliminary stage projects 5 0
Other 94 0
Restricted stock
Cost of goods sold 108 —
Research and development 58 125
Selling, general and administrative 2,050 437
Preliminary stage projects 11 0
Other 138 0
Total equity classified awards 4,044 562
Liability Classified Awards
Restricted stock
Selling, general and administrative 193 —
Stock appreciation rights
Research and development — 348
Selling, general and administrative 21 15
Total liability classified awards 214 363
Total stock-based compensation $ 4,258 $ 925

~~Table of Contents~~

~~GEVO, INC.~~


	Three months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Equity Classified Awards
Stock options
Cost of goods sold	$	89	$	—	$	174	$	—
Research and development	83		—		134		—
Selling, general and administrative	1,625		—		3,069		—
Preliminary stage projects	3		—		8		—
Other	99		—		193		—
Restricted stock
Cost of goods sold	109		—		217		—
Research and development	95		121		153		246
Selling, general and administrative	1,963		737		4,013		1,174
Preliminary stage projects	13		—		24		—
Other	141		—		279		—
Total equity classified awards	4,220		858		8,264		1,420
Liability Classified Awards
Restricted stock
Selling, general and administrative	(381)		—		(188)		—
Stock appreciation rights
Research and development	(126)		(159)		(126)		189
Selling, general and administrative	(26)		(7)		(5)		8
Total liability classified awards	(533)		(166)		(319)		197
Total stock-based compensation	$	3,687	$	692	$	7,945	$	1,617

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

Stock option award activity. Stock option activity under the Company’s stock incentive plans and changes during the ~~three~~six months ended ~~March 31,~~June 30, 2022, were as follows:


	Number of Options	Weighted-Average Exercise Price (1)		Weighted-Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Options outstanding at December 31, 2021	4,746,368	$	5.11	9.6	$	—
Granted	16,791	$	3.68		$	—
Canceled or forfeited	(220,255)	$	5.56		$	—
Exercised	—	0			$	—
Options outstanding at June 30, 2022	4,542,904	$	—	9.1	$	—
Options vested and expected to vest at June 30, 2022	18,186	$	39.69	0.5	$	—

Number of Options
Weighted-Average Exercise Price (1) Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value
Options outstanding at December 31, 2021 4,739,940 $ 5.14 9.6 $ —
Granted — 0
Canceled or forfeited (174,187) $ 5.63
Exercised — 0
Options outstanding at March 31, 2022 4,565,753 $ 5.12 9.4 $ —
Options exercisable at March 31, 2022 1,520 $ 427.69 4.4 $ —

(1) Exercise price of options outstanding range from $4$2.73 to ~~$99,300~~$19,620.00 as of ~~March 31,~~June 30, 2022. The higher range end of the range is ~~related~~due to historical stock reverse splits.

NoTable of Contents ~~stock options vested during the three months ended March 31, 2022~~.

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

As of ~~March 31,~~June 30, 2022, the total unrecognized compensation expense, net of estimated forfeitures, relating to stock options was ~~$16.6~~$14.6 million, which is expected to be recognized over the remaining weighted-average period of approximately ~~3.6~~3.3 years.

Restricted stock. Non-vested restricted stock awards and the changes during the ~~three~~six months ended ~~March 31,~~June 30, 2022, were as follows:


		Number of Shares	Weighted-Average Grant-Date Fair Value
						Number of Shares	Weighted-Average Grant-Date Fair Value
Outstanding at December 31, 2021	Outstanding at December 31, 2021	7,094,785	$	3.93	Outstanding at December 31, 2021	6,882,502	$	3.77
Granted	Granted	—	$	—	Granted	165,174	$	4.45
Exercised	Exercised	(165,870)	$	1.09	Exercised	(209,398)	$	2.63
Canceled or forfeited	Canceled or forfeited	(174,268)	$	4.53	Canceled or forfeited	(252,801)	$	4.87
Vested	Vested	(364)	$	2.30	Vested	(364)	$	2.30

Non-vested at March 31, 2022		6,754,283	$	4.01
Non-vested at June 30, 2022					Non-vested at June 30, 2022	6,585,113	$	4.01

The total fair value of restricted stock that vested during the ~~three~~six months ended ~~March 31,~~June 30, 2022, was ~~nil.~~$0.6 million. As of ~~March 31,~~June 30, 2022, the total unrecognized compensation expense, net of estimated forfeitures, relating to restricted stock awards was ~~$19.4~~$17.2 million, which is expected to be recognized over the remaining weighted-average period of approximately ~~2.9~~2.7 years. As of ~~March 31,~~June 30, 2022, we had recorded a liability of ~~$1.0~~$0.5 million for earned and unvested liability-classified restricted stock awards based on the fair value of our common stock as of ~~March 31,~~June 30, 2022.

~~15.~~14.Income Taxes

The Company has incurred operating losses since inception, therefore no provision for income taxes was recorded and all related deferred tax assets are fully ~~reserved for.~~reserved. We continue to assess the impact of a deferred tax asset as it relates to income taxes.

~~16.~~15.Commitments and Contingencies

Legal matters. From time to time, the Company has been, and may again become, involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any litigation and is not aware of any

~~Table of Contents~~

~~GEVO, INC.~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

pending or threatened litigation against the Company that it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.

Indemnifications. In the ordinary course of its business, the Company makes certain indemnities under which it may be required to make payments in relation to certain transactions. As of ~~March 31,~~June 30, 2022, the Company did not have any liabilities associated with indemnities.

In addition, the Company, as permitted under Delaware law and in accordance with its amended and restated certificate of incorporation and second amended and restated bylaws, in each case, as amended to date, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company’s request in such capacity. The duration of these indemnifications, commitments, and guarantees varies and, in certain cases, is indefinite. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. No such losses have been recorded to date.

Environmental liabilities. The Company’s operations are subject to environmental laws and regulations adopted by various governmental authorities in the jurisdictions in which it operates. These laws require the Company to investigate and remediate the effects of the release or disposal of materials at its locations. Accordingly, the Company has adopted policies, practices and procedures in the areas of pollution control, occupational health and the production, handling, storage and use of hazardous materials to prevent material environmental or other damage, and to limit the financial

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

liability which could result from such events. Environmental liabilities are recorded when the Company’s liability is probable, and the costs can be reasonably estimated. No environmental liabilities have been recorded as of ~~March 31,~~June 30, 2022.

In February 2022, an incident occurred at one of the anaerobic digesters that is part of NW Iowa RNG that resulted in the accidental discharge of a mixture of water and manure into the environment. We promptly notified the Iowa Department of Natural Resources (the "DNR") and began mitigation work to minimize the impact of the discharge. The DNR has issued a notice of violation in connection with the discharge. This matter was resolved with the DNR in July 2022 through an administrative consent order and damages of $10,000 were assessed.

In April 2022, ~~two~~2 separate incidents occurred at ~~two~~2 of the anaerobic digesters that are part of NW Iowa RNG that resulted in the accidental discharge of very small amounts of water and manure into the environment. The DNR has issued notices of violation in connection with the ~~two~~2 discharges.

There is a possibility that the DNR will initiate an enforcement action with respect to the April 2022, discharges described above that could result in a monetary sanction being levied against Gevo for the accidental discharges. We do not believe that any such monetary sanctions would be material to the Company.

The Company's investment in Juhl is pledged as a collateral for 2 commitments related to a purchase of wind electricity for the Luverne Facility, as well as 100% of RCWF's renewable energy credits. Gevo has a commitment to purchase all of RCWF's electricity. The portion not used by the Luverne Facility is charged to the Company at a lower price. The estimated commitments as of June 30, 2022, and thereafter are shown below:

~~17.~~


Year ending December 31,	Electricity Above Use (estimated)		Renewable Energy Credits
2022 (remaining)	$	257	$	150
2023	440		150
2024	440		150
2025	440		150
2026	—		150
2027 and thereafter	—		1,900
Total commitments	$	1,577	$	2,650

16.Fair Value Measurements

Accounting standards define fair value, outline a framework for measuring fair value, and detail the required disclosures about fair value measurements. Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. Standards establish a hierarchy in determining the fair market value of an asset or liability. The fair value hierarchy has three levels of inputs, both observable and unobservable. Standards require the utilization of the highest possible level of input to determine fair value.

Level 1 – inputs include quoted market prices in an active market for identical assets or liabilities.

Level 2 – inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data.

Level 3 – inputs are unobservable and corroborated by little or no market data.

2123

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The carrying value and fair value, by fair value hierarchy, of the Company's financial instruments at ~~March 31,~~June 30, 2022, and December 31, 2021, respectively, are as follows (in thousands):


				Fair Value Measurements at March 31, 2022									Fair Value Measurements at June 30, 2022
		Fair Value at March 31, 2022		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Fair Value at June 30, 2022		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Recurring	Recurring									Recurring
Marketable securities	Marketable securities									Marketable securities
U.S. Treasury notes	U.S. Treasury notes	$	199,106	$	199,106	$	—	$	—	U.S. Treasury notes	$	161,438	$	161,438	$	—	$	—
U.S. Government-sponsored enterprise securities	U.S. Government-sponsored enterprise securities	99,431		99,431		—		—		U.S. Government-sponsored enterprise securities	136,193		136,193		—		—

Other	Other									Other
Liability-classified restricted stock awards	Liability-classified restricted stock awards	894		894		—		—		Liability-classified restricted stock awards	514		514		—		—

Total recurring	Total recurring	$	299,431	$	299,431	$	—	$	—	Total recurring	$	298,145	$	298,145	$	—	$	—


				Fair Value Measurements at December 31, 2021									Fair Value Measurements at December 31, 2021
		Fair Value at December 31, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Fair Value at December 31, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Recurring	Recurring									Recurring
Marketable securities	Marketable securities									Marketable securities
U.S. Treasury notes	U.S. Treasury notes	$	225,792	$	225,792	$	—	$	—	U.S. Treasury notes	$	225,792	$	225,792	$	—	$	—
U.S. Government-sponsored enterprise securities	U.S. Government-sponsored enterprise securities	113,944		113,944		—		—		U.S. Government-sponsored enterprise securities	113,944		113,944		—		—

Other	Other									Other
Liability-classified restricted stock awards	Liability-classified restricted stock awards	702		702		—		—		Liability-classified restricted stock awards	894		894		—		—

Total recurring	Total recurring	$	340,438	$	340,438	$	—	$	—	Total recurring	$	340,630	$	340,630	$	—	$	—

There were no transfers to or from Level 2 or Level 3 in the ~~three~~six months ended ~~March 31,~~June 30, 2022.

For the 2021 Bonds, the fair values are estimated using the Black-Derman-Toy interest rate lattice framework. The effective maturity of the 2021 Bonds was assumed to be April 1, 2024 (three years from issuance) with repayment of 100% of principal on that date. The impact of the Company's optional redemption feature, effective October 1, 2022, is appropriately captured by the Black-Derman-Toy interest rate lattice. The carrying values and estimated fair values of the 2021 ~~bonds~~Bonds as of ~~March 31,~~June 30, 2022, are summarized as follows:

March 31, 2022
Carrying Value Estimated Fair Value
2021 Bonds $ 68,155 $ 66,657


	June 30, 2022
	Carrying Value		Estimated Fair Value

2021 Bonds	$	66,853	$	65,994

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

17.Shareholders' Equity

Share Issuances

In February 2018, the Company commenced an at-the-market offering program, which allows it to sell and issue shares of its common stock from time to time. In 2021, the at-the-market offering program was amended to provide a total capacity of $500.0 million. As of June 30, 2022, the Company has remaining capacity to issue up to approximately $360.6 million of common stock under the at-the-market offering program.

On June 8, 2022, the Company completed a registered direct offering pursuant to a securities purchase agreement with certain institutional investors providing for the issuance and sale by the Company of an aggregate of 33,333,336 shares of the Company’s common stock at a price of $4.50 per share accompanied by 33,333,336 Series 2022-A warrants to purchase shares of the Company’s common stock (each, a “Series 2022-A Warrant”) (the “June 2022 Offering”). The Series 2022-A Warrants are exercisable for a term of five years from the date of issuance at an exercise price of $4.37 per Series 2022-A Warrant. As of June 30, 2022, none of the Series 2022-A Warrants had been exercised.

The net proceeds to the Company ~~has~~from the June 2022 Offering were $139.0 million, after deducting placement agent fees, advisory fees and other estimated offering expenses payable by the Company, and not including any future proceeds from the exercise of the Series 2022-A Warrants. The Company intends to use the net proceeds from the June 2022 Offering to ~~not~~fund future operations and capital projects ~~elected~~.

Warrants

The Company evaluated the Series 2022-A Warrants for liability or equity classification and determined that equity treatment was appropriate because the Series 2022-A Warrants do not meet the definition of liability instruments.

The Series 2022-A Warrants are classified as component of permanent equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the shares of common stock with which they were issued, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, and permit the holders to receive a fixed number of shares of common stock upon exercise. In addition, the Series 2022-A Warrants do not provide any guarantee of value or return. The Company valued the Series 2022-A Warrants at issuance using the Black-Scholes option pricing model and determined the fair value ~~option for any~~ of the Series 2022-A Warrants to purchase the Company’s common stock at $92.9 million. The key inputs to the valuation model included a weighted average volatility of 151.1%, a risk-free rate of 2.86% and an expected term of five years.

While the Company believes that its ~~instruments.~~valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

On February 17, 2022, the Series K warrants expired with 7,126 unexercised warrants.

The following table sets forth information pertaining to shares issued upon the exercise of warrants:


	Issuance Date	Expiration Date	Exercise Price as of June 30, 2022		Shares Underlying Warrants on Issuance Date	Shares Issued upon Warrant Exercises as of June 30, 2022		Shares Underlying Warrants Outstanding as of June 30, 2022
Series 2020-A Warrants (1)	7/6/2020	7/6/2025	$	0.60	30,000,000	29,914,069		85,931
Series 2022-A Warrants (1)	6/8/2022	6/7/2027	$	4.37	33,333,336	—		33,333,336
Total Warrants					63,333,336	29,914,069	—	33,419,267

(1) Equity-classified warrants.

2225

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

During the six months ended June 30, 2022, common stock was issued as a result of the exercise of warrants as shown below (dollars in thousands):


	Common Stock Issued	Proceeds
Series 2020-A Warrants	4,677	$	3

18.Segments

The Company's chief operating decision maker is provided with and reviews a monthly executive package which separately identifies its business segments based on the nature of the products and services offered through each of its consolidated legal entities. In January 2021, the Company began to separately identify the Renewable Natural Gas Segment in the monthly executive package. As such, the Company has ~~determined that it ha~~organized its operations and activities intos 3 ~~operati~~reportable ng segments: (i) Gevo segment; (ii) Agri-Energy segment; (iii) Renewable Natural Gas segment. Transactions between segments are eliminated in consolidation.

Gevo segment. The Gevo segment is responsible for all research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products, such as hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the chemical industry, such as ethylene and butenes; plastics and materials; and other chemicals. The Gevo segment also develops, maintains and protects its intellectual property portfolio, provides corporate oversight services, and responsible for development and construction of our Net-Zero projects.

Agri-Energy segment. The Agri-Energy segment is currently responsible for the operation of the Company’s Luverne Facility, development and optimization of the production of isobutanol, ethanol and related products.

Renewable ~~natural gas~~Natural Gas segment. The Renewable Natural Gas segment produces low-carbon methane from manure for the production of RNG.

2326

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Three Months Ended March 31,
2022 2021
Revenues:
Gevo $ 63 $ 13
Agri-Energy 169 80
Renewable Natural Gas — —
Consolidated $ 232 $ 93
Loss from operations:
Gevo $ (12,124) $ (7,763)
Agri-Energy (3,808) (2,047)
Renewable Natural Gas (23) (68)
Consolidated $ (15,955) $ (9,878)
Acquisitions of patents, plant, property and equipment:
Gevo $ 4,438 $ 253
Agri-Energy 3,947 10
Renewable Natural Gas 10,393 5,169
Consolidated $ 18,778 $ 5,432


	Three Months Ended June 30, 2022
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Revenues	$	18	$	71	$	—	$	89
Loss from Operations	$	(13,025)	$	(3,113)	$	23	$	(16,115)
Acquisitions of patents, plant, property and equipment	$	11,870	$	328	$	8,275	$	20,473

	Three Months Ended June 30, 2021
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Revenues	$	346	$	—	$	—	$	346
Loss from Operations	$	(11,915)	$	(7,183)	$	—	$	(19,098)
Acquisitions of patents, plant, property and equipment	$	588	$	1,898	$	11,932	$	14,418

	Six Months Ended June 30, 2022
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Revenues	$	81	$	240	$	—	$	321
Loss from Operations	$	(25,149)	$	(6,921)	$	—	$	(32,070)
Acquisitions of patents, plant, property and equipment	$	16,308	$	4,275	$	18,668	$	39,251

	Six Months Ended June 30, 2021
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Revenues	$	359	$	—	$	—	$	359
Loss from Operations	$	(19,678)	$	(9,310)	$	(68)	$	(29,056)
Acquisitions of patents, plant, property and equipment	$	841	$	1,908	$	17,101	$	19,850

March 31, 2022 December 31, 2021
Total assets
Gevo $ 450,048 $ 484,528
Agri-Energy 65,834 64,008
Renewable Natural Gas 122,778 117,940
Consolidated (1) $ 638,660 $ 666,476


	June 30, 2022
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Total assets	$	601,313	$	64,940	$	108,358	$	774,611

	December 31, 2021
	Gevo		Agri-Energy		Renewable Natural Gas		Consolidated
Total assets	$	484,528	$	64,008	$	117,940	$	666,476

19.Subsequent Events

~~In April~~On July 21, 2022, ~~Gevo signed an amendment to its Fuel Supply~~the Company entered into a Water Purchase Agreement with ~~Rock River Jerseys, LLC ("RRJ"~~Kingbrook Rural Water System (“Kingbrook”) to ~~reimburse RRJ for part of the cost to install~~construct and operate ~~covers~~a rural water distribution system for the ~~lagoons at~~Net-Zero 1 Project. Pursuant to the ~~RRJ dairy. This~~

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Agreement, the Company will ~~allow Gevo to optimize efficiencies~~pay Kingbrook a one-time system development charge of $6.7 million, with 50% of such payment due in August 2022 and ~~could significantly improve~~ the ~~carbon intensity score at NW Iowa RNG.~~remaining 50% due over the 24 months following execution.

~~The Company's estimated share~~

On July 25, 2022, the Company closed on the purchase of ~~the total capital cost~~approximately 245 acres near Lake Preston, South Dakota for the ~~improvements is~~Net-Zero 1 Project. The total net purchase price for the land was approximately ~~$1.9~~$6.0 million. ~~The installation is expected to be completed early in the third quarter of 2022.~~

2428

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used anywhere in this Report, the words “expect,” “believe,” “anticipate,” “estimate,” “intend,” “plan” and similar expressions are intended to identify forward-looking statements. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. These forward-looking statements include, among other things, statements about: the impact of the novel coronavirus ("COVID-19") pandemic on our business, our financial condition, our results of operation and liquidity, our ability to finance and construct our Net-Zero 1 Project (as defined below), our ability to produce our products at our demonstration facility in Luverne, Minnesota (the “Luverne Facility”) or elsewhere, our ability to meet production, financial and operational guidance, our strategy to pursue low-carbon or "net-zero" carbon renewable fuels for sale into California and elsewhere, our ability to replace our fossil-based energy sources with renewable energy sources at our Net-Zero 1 Project, our Luverne Facility and elsewhere, our ability and plans to construct a greenfield commercial hydrocarbon ~~facility~~facilities to produce sustainable aviation fuel ("SAF") and renewable premium gasoline/isooctane, our ability to raise additional funds to finance our business, our ability to perform under our existing off-take agreements and other supply agreements we may enter into in the future, our ability to successfully construct and operate our renewable natural gas ("RNG") project in Iowa, our ability to produce renewable hydrocarbon products at a commercial level and at a profit, the availability of, and market prices for, government economic incentives to the renewable energy market, achievement of advances in our technology platform, the availability of suitable and cost-competitive feedstocks, our ability to gain market acceptance for our products, the expected cost-competitiveness and relative performance attributes of our products, our strategy to pursue alcohol-to-SAF, additional competition and changes in economic conditions and the future price and volatility of petroleum and products derived from petroleum. Important factors could cause actual results to differ materially from those indicated or implied by forward-looking statements such as those contained in documents we have filed with the U.S. Securities and Exchange Commission (the “SEC”), including this Report in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” our Annual Report on Form 10-K for the year ended December 31, 2021 (our “2021 Annual Report”), including Item 1A. "Risk Factors" of our 2021 Annual Report and subsequent reports on Form 10-Q. All forward-looking statements in this Report are qualified entirely by the cautionary statements included in this Report and such other filings. These risks and uncertainties or other important factors could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this Report. These forward-looking statements speak only as of the date of this Report. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing the Company’s views as of any date subsequent to the date of the filing of this Report.

Unless the context requires otherwise, in this Report the terms “we,” “us,” “our” and the “Company” refer to Gevo, Inc. and its subsidiaries.

The following discussion should be read in conjunction with our unaudited consolidated financial statements and the related notes and other financial information appearing elsewhere in this Report. Readers are also urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business, including, without limitation, the disclosures in our 2021 Annual Report.

Company Overview

Gevo, Inc. (Nasdaq: GEVO), a Delaware corporation founded in 2005, is a growth-oriented company with the mission of solving the problem of greenhouse gas emissions for those sectors of the transportation industry that are not amenable to electrification or hydrogen. We believe that the market size for hydrocarbon fuels will continue to remain significant in the long-term even with the rapid adoption of electric vehicles and hydrogen technologies. We also believe that we can achieve at least one billion gallons of hydrocarbon production and sales by 2030.

We are focused on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels, such as SAF, with the potential to achieve a “net-zero” greenhouse gas ("GHG") footprint. We believe

that this addresses the global need of reducing GHG emissions with "drop in" sustainable alternatives to petroleum fuels. We use Argonne National Laboratory’s GREET (Greenhouse gases, Regulated Emissions, and Energy use in Transportation) model (the "GREET Model") to measure, predict and verify GHG emissions across the life cycle of our products. The "net-zero" concept means ~~that~~ we expect to produce fuels that could have a carbon neutral or a net-zero GHG footprint across the whole of the life cycle of the fuel from capture of renewable carbon, through production, and subsequent burning of the fuel in, for example, a jet engine.

Our primary market focus, given current demand and growing customer interest, is SAF. We believe ~~that~~ we also have commercial opportunities for other renewable hydrocarbon products, such as RNG, hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the chemical industry, such as ethylene and butenes; plastics and materials; and other chemicals. The global fuel consumption by commercial airlines was an all-time high of 95 billion gallons in 2019. However, due to the COVID-19 pandemic, fuel consumption dropped to 52 billion gallons in 2020 and reached 57 billion gallons in 2021.

We believe that there is a growing and significant market demand for SAF based on a number of factors, including:


			●			The International Air Transport Association ("IATA") 77th Annual General Meeting approved a resolution for the global air transport industry to achieve net-zero carbon emissions by 2050. IATA has 288 airline members, including Alaska Airlines, American Airlines, Delta Air Lines, FedEx Express, United Airlines and UPS Airlines.
			●			Starting on March 1, 2020, Delta Air Lines committed spending $1 billion over the next 10 years on its objective around mitigating emissions from its global business going forward. Delta will invest in driving innovation, advancing clean air travel technologies, accelerating the reduction of carbon emissions and waste, and establishing new projects to mitigate the balance of emissions.
			●			The oneworld® alliance committed to a target of 10% SAF use across the alliance by 2030 and plans to reach net zero emissions by 2050.

We believe we possess the ~~technology and know-how~~ability to convert various carbohydrate ~~feeds~~feedstocks through a fermentation process into alcohols and then transform the alcohols into renewable fuels and ~~materials.~~materials, through a combination of our own technology, know-how, engineering, and licensing of technology and engineering from Axens North America, Inc. ("Axens"). While we expect our ~~first~~ major capital deployments to focus on the production of SAF, we recognize ~~that~~ there are opportunities to operate in several different renewable fuels and materials markets and we will pursue those opportunities when appropriate based on customer interest, access to capital, and expected investment returns.

Our production processes use carbohydrates as a feedstock. Carbohydrates are plant matter that result from photosynthesis. Photosynthesis is the natural process by which carbon dioxide is captured from the air by plants. The carbon in carbohydrates is therefore renewable because it is already in the atmosphere. The carbohydrates are fermented to produce alcohol intermediate products (e.g., ethanol or isobutanol). The alcohol-based intermediates are then chemically processed to make renewable hydrocarbons. To achieve net-zero carbon intensity ("CI") across the whole life cycle of the products, we believe:


			●			carbohydrates with a low CI score must be used in production;
			●			the energy (electricity and heat source) used in production must be de-fossilized; and
			●			the products cannot contain fossil-based carbon.

We believe sustainably grown industrial field corn (i.e., corn that is grown with precision agricultural techniques and low-till or no till cultivation to conserve nutrients, prevent water runoff, and erosion) is ~~a good~~the best feedstock to commercialize initially because:


			●			it produces a significant amount of protein and vegetable oil for nutritional products on a per acre basis while also producing an abundance of low CI carbohydrates that can be captured and used as a feedstock for fuels and chemicals;
			●			the protein and oil that are produced, ~~are~~ easily separated, and sold as co-products into the food chain markets. The protein and oil revenue serves to offset the cost of the corn feedstock;


			●			we believe ~~that~~ the carbon footprint of growing corn can be negative, according to calculations completed with the GREET Model, when a full suite of climate-smart agricultural practices ~~are~~is employed on appropriate acres of ~~cropland.~~cropland;
			●			we believe the corn can achieve lower CI scores when grown with climate-smart agricultural techniques than waste raw materials or wood; and
			●			we believe that residual carbohydrates from corn are the lowest cost carbohydrates available as a renewable raw material, and the production is proven and scalable.

We believe ~~that~~ utilizing sustainable agriculture practices to help solve GHG problems is a breakthrough that addresses the problem of GHGs without compromising sustainability or food supply. We also believe that it will be possible to create an incentive structure that rewards farmers to lower the CI score of their agricultural products and create a cycle of continuous improvement to their overall sustainability footprint.

Net-Zero Projects

In early 2021, we announced the concept of “Net-Zero Projects” as a series of planned facilities to produce energy dense liquid hydrocarbons using renewable energy and our proprietary technology. The concept of a Net-Zero Project is to convert renewable energy (e.g., photosynthetic, wind, renewable natural gas, biogas) from a variety of sources into energy dense liquid hydrocarbons that, when burned in traditional engines, have the potential to achieve net-zero GHG emissions across the whole lifecycle of the liquid fuel: from the way carbon is captured from the atmosphere, processed to make liquid fuel products, and ~~including the end use (burning~~burnt as a fuel for cars, planes, trucks and ~~ships).~~ships.

We announced ~~that~~ our initial Net-Zero ~~project~~Project (“~~Net-Zero 1 Project"~~NZ1") is ~~currently~~ planned to be constructed at Lake Preston, South Dakota. ~~We expect that the Net-Zero 1 Project will have the capability~~NZ1 is expected to produce approximately 55 million gallons per year ("MGPY") of SAF or 62 MGPY of total hydrocarbon volumes, which would satisfy part of the more than 350 MGPY of financeable SAF and hydrocarbon supply agreements that are currently in place. The liquid hydrocarbons ~~that~~ when burned are expected to have a “net-zero” GHG footprint. ~~We currently expect the Net-Zero 1 Project to have a capacity of approximately 60 MGPY of hydrocarbons~~Along with the ~~majority being SAF, along with naphtha and diesel blendstocks. All of the production for the Net-Zero 1 Project is backed by our current portfolio of take-or-pay contracts. Along with~~ hydrocarbons, we expect to produce approximately 420 million pounds per year of high-value protein products for use in the food chain and more than 30 million pounds per year of corn oil. ~~Significant progress has been made to date on site development, engineering of the facility, and permitting.~~ Our products will be produced in ~~two stages. The~~three stages; the first stage is the milling of the corn and production of protein, oil, and carbohydrates, the second stage involves alcohols production by fermentation and the ~~second~~third stage is the conversion of such alcohols into hydrocarbons. We have ~~been working with~~an exclusive license in the United States from Axens ~~North America, Inc. ("Axens")~~to ~~engineer~~ the ~~alcohols-to-hydrocarbon side of~~technology and plant designs to convert alcohols to hydrocarbon fuels. Axens will also provide certain process guarantees for the production ~~facility given their~~process. Additionally, Axens has extensive commercial experience ~~with~~in the technology, design, and deployment of the unit operations needed to convert alcohols to hydrocarbon fuels, based on their ~~process and~~experience in the ~~performance guarantees that cover the entire alcohol-to-hydrocarbon process.~~petrochemical industry. The fermentation side of the ~~production~~ facility is being engineered with companies that have extensive experience in fermentation and ~~ag-based~~agriculture-based facilities. We ~~also expect to execute contracts to supply wind power and green hydrogen to~~believe that by using known commercial technologies, the plant ~~as well as to operate a wastewater treatment plant, which~~design is expected to generate a significant amount of biogas. We expect to select an Engineering, Procurement, and Construction company by the end of the year to lead the construction phase of the Net-Zero 1 Project. We also expect to begin purchasing long lead time equipment later this year to enable completion of the facility in 2025. We are preparing for other major milestones such as site acquisition, preparation and construction work. Engineering work is on track, and we expect to break ground in late 2022, with the target completion date for the plant in 2025. In addition, substantial due diligence work is being performed on the next Net-Zero Projects, including review of potential sites against project criteria.substantially de-risked.

The transition to an ethanol-to-SAF design from Gevo’s original isobutanol-to-SAF and isooctane design has at NZ1 resulted in an expected increase of output capacity which should result in increased cash flow. Gevo’s ethanol-to-SAF engineering design work to date has resulted in a significant uplift in volumes and cash flows per unit of capital invested.

~~Alcohols-to-SAF Strategy~~

The NZ1 project is on schedule with initial volumes of SAF expected to be delivered in 2025. Key NZ1 development milestones are:

~~Alcohols can be converted to hydrocarbon products with catalytic chemical processing techniques analogous to those used~~

Through year-end 2022:


			●			Complete the purchase of the land for NZ1 in Lake Preston, South Dakota. (this purchase was completed in July 2022)
			●			Execute commercial development, build, own and operate agreements for water, wind energy and green hydrogen
			●			Select engineering, procurement, and construction ("EPC") contractor
			●			Select fabricator for hydrocarbon plant modules
			●			Substantial completion of front-end engineering design ("FEED")
			●			Break ground and begin site preparation at Lake Preston
			●			Order long lead equipment

Through the first-half 2023:


			●			Close the construction financing, including non-recourse debt

Gevo is also in the ~~petrochemical industry.~~process of identifying and performing early site development work for additional SAF production locations. These sites include several greenfield locations that are particularly advantageous in terms of potential economics, opportunities to decarbonize, and time to market. In ~~October 2021,~~addition, we ~~signed an agreement~~are pursuing prospects with ~~Axens~~several existing ethanol plant sites. Existing ethanol plants need to be decarbonized with renewable energy or de-fossilized energy and/or carbon sequestration. Gevo has developed a preferred list of partners and sites with decarbonization in mind and is engaged in preliminary feasibility and development discussions with several of them. We plan to give priority to existing plant sites that have attractive potential economics and high predictability of timeline for their technology on this process since they have already scaled it up and they have licensed it to many commercial production facilities. The agreement establishes a strategic alliance aimed at accelerating the commercialization of sustainable alcohol-to-SAF projects in the United States. As part of the alliance, Axens brings technologies with over 60 related patents, engineering packages, proprietary catalysts and certain proprietary equipment required to convert alcohols into SAF and they will provide certain process guarantees to us.decarbonization.

Luverne Facility

~~The Luverne Facility was originally constructed in 1998 and is located on approximately 55 acres of land, which contains approximately 50,000 square feet of building space.~~ The Luverne Facility continues to provide valuable knowledge and experience for the future strategic growth of the Company and its billion-gallon initiative. As a development site, operations will continue to be tailored to support a focus on advancing our technology, testing, and optimizing alternative feedstocks, yeast strains, and unit operations as well as partnership development for integrated GHG reductions. It is well equipped and positioned for optimization of the decarbonization and business ~~circuits~~cycle from feedstock to energy solutions. The site provides a unique opportunity to showcase our decarbonization and business systems and raise awareness for future partnerships, investors, and local communities. As a development site, the Luverne plant may operate intermittently between projects and activities.

Renewable Natural Gas Projects

In 2019, we began developing RNG projects. Manure can be digested anaerobically to produce biogas, which is then upgraded to pipeline quality RNG. RNG has value in markets such as California when injected and shipped through a natural gas pipeline. There is also value to Gevo’s hydrocarbon production process by giving us another option to achieve carbon negative GHG emissions on our renewable hydrocarbon products. The hydrocarbon products resulting from such a decarbonization process have lower CI scores and increased market value, in addition to having a more positive impact on the environment.Our dairy farm partners realize a variety of benefits including improved operational and environmental compliance options. These services facilitate long-term relationships with project hosts that may serve as a source for future projects and relationships.

~~We developed Gevo's initial~~Gevo’s RNG project in Northwest Iowa ~~(“NW Iowa RNG”~~(the “RNG Project”) ~~to generate~~has been producing biogas and is now upgrading and injecting RNG into a natural gas pipeline. The RNG Project generates renewable natural gas captured from dairy cow manure. The manure ~~which will be~~for the RNG Project is supplied by three ~~dairies~~dairy farms located in Northwest Iowa totaling over 20,000 milking cows. ~~We completed most of~~When at full operational capacity, the construction efforts at the end of 2021. In January 2022, we began the process of bringing it online. All of the digesters are currently in the start-up phase and are expected to reach steady production levels in the second quarter of 2022.

~~When fully operational, NW Iowa~~ RNG Project is expected to generate approximately 355,000 MMBtu of RNG per year. ~~We expect to sell this~~Gevo's revenue from the RNG into the California market under the dispensing agreements BP Canada Energy Marketing Corp. and BP Products North America Inc. (collectively, “BP”) has in place with Clean Energy Fuels Corp. The majority of the revenues areProject is expected to ~~commence in late 2022 or early in 2023 and will be derived~~come from ~~two main components. The first component consists of the~~ sales of RNG and ~~the second component consists of~~from the environmental attributes associated with the RNG sales, including the attributes available from ~~California’s~~California's Low Carbon Fuel Standard ("LCFS") program and the U.S. Environmental Protection ~~Agency’s~~Agency's Renewable Fuels Standard ("RFS"). Gevo expects to be able to get approval for Renewable Identification Numbers (“RINs”) through RFS and carbon credits from LCFS ~~and RFS are state and federal programs, respectively, that provide incentives for the supply of low carbon renewable fuels in California and in the United States.~~later this year or next year.

We ~~are also planning~~have been making improvements and incremental expansions to ~~make improvements to this~~the RNG ~~project~~Project by investing in capital projects that may significantly improve its CI score and revenue, which in turn strengthen the overall economics of the project.

Gevo’s current estimated share of the capital cost for those improvements is approximately $1.9 ~~million.~~million, which are 40% complete through the second quarter of 2022. The improvement and expansion work is on budget and expected to be completed early in the third quarter of 2022. In addition, in June 2022, we amended our lease with a dairy to provide additional manure, which may increase our RNG production in the future.

We have strong relationships throughout the industry supply chain from technology and equipment providers to feedstock owners, and RNG off-takers. We believe ~~that~~ the trust and ~~strong~~ reputation we have attained in combination with our understanding of the various and complex environmental attributes gives us a competitive advantage. We leverage our relationships to identify and execute new project opportunities. Typically, new development opportunities come from our existing relationships with dairy owners who value our ~~strong~~ reputation in the industry.

We exercise financial discipline in pursuing projects by targeting attractive risk-adjusted project returns, whether selling RNG into the markets or using it to lower CI scores at our Net-Zero Projects. We will monitor biogas supply availability across our portfolio and seek to maximize production at existing projects by expanding operations when economically feasible.

Verity and Carbon Tracking

Capturing and accurately counting carbon data across the whole of the business system is a critical part of Gevo’s business model, and the CI scores across the whole of the carbon ~~lifecycle,~~life cycle, from feedstock through the burning of fuels. Through the use of the GREET Model and a field level tracking approach, ~~using Verity Tracking,~~ our goal is to obtain carbon credits for the improved agricultural practices related to ~~climate smart~~climate-smart agriculture such as precision agriculture and tillage practices (i.e., low till and no-till cultivation). We believe there is an opportunity to document, verify, and monetize that carbon value which is not otherwise counted and reward value chain partners, including farmers, for improving sustainability. Gevo’s current economic projections do not take into account this upside in value.

Verity Tracking ("Verity") is a joint venture between Gevo and Blocksize Capital GmbH ("Blocksize") to develop and commercialize carbon value and other sustainable attributes. Verity ~~has developed and will continue to develop a proprietary platform based on Distributed Ledger Technology (“DLT” or commonly called “blockchain”). Verity~~ is developing the ~~capability~~tools, techniques, software, data access to track carbon scores and other sustainability attributes ~~such as carbon reductions through~~using “blockchain” technology. The benefit is having audited, transparent, immutable sustainability data attached to biofuels and is expected to be valuable to our customers, colleague companies, and partners. Gevo and Blocksize have identified a ~~value chain with the utmost data security, audit capabilities and immutability. In addition,~~series of internal milestones that Verity will ~~have~~need to achieve over the ~~ability~~next few quarters to ~~work with all aspects~~expand the joint venture into a stand-alone business unit, either as part of ~~value chain decarbonization and create~~Gevo or as a separate entity.

~~path for monetization of~~Verity has continued to develop third-party partnerships that ~~carbon reduction, through processes such as “tokenization.”~~will contribute to its development objectives over the coming quarters. Verity and Gevo ~~have recently~~ partnered with Farmers Edge Inc. ("Farmers Edge"), a company dedicated to helping farmers track data and improve agricultural decision making. As of ~~December~~March 31, ~~2021,~~2022, Farmers Edge reported over ~~3,800 growers with over 18~~17.3 million subscribed acres having implemented their solutions.

Gevo has begun to develop the agricultural ~~Climate Smart~~Climate-Smart Data for some of the key farms that would supply its ~~Net-Zero 1~~NZ1 plant. Gevo intends to work with Verity to accurately account for and determine value for the carbon reductions captured in feedstocks, both during fuel production and in final products, to help our customers and value chain partners achieve their sustainability goals.

Market Development

Gevo now has more than 350 MGPY of financeable SAF and hydrocarbon fuel supply agreements, which are expected to support project debt financing. This level of demand would require three additional plants equal in size to the expected capacity of NZ1 to be built over the next four years to satisfy those agreements. Based on current market projections and operating assumptions, these agreements collectively represent approximately $2.1 billion in expected

revenue per year, inclusive of the environmental benefits value. A list of the recently announced supply agreements is noted below:

Recently Announced Supply Agreements

Date Signed

Customer

Product

Volume (MGPY)

Term (Years)

June 2022

Finnair

SAF

7.0

June 2022

Japan Airlines

SAF

5.3

July 2022

Aer Lingus

SAF

6.3

July 2022

Alaska Airlines

SAF

37.0

July 2022

American Airlines

SAF

100.0

Recent Developments

~~Delta Air Lines.~~Equity Offering. On ~~March 22,~~June 8, 2022, ~~we signed~~the Company completed a ~~"take-or-pay"~~registered direct offering pursuant to a securities purchase agreement with ~~Delta Air Lines, Inc. ("Delta")~~certain institutional investors and received net proceeds of $139.0 million (after placement agent fees, advisory fees and estimated offering expenses) to fund future operations and capital projects. As part of the offering, the Company issued 33,333,336 Series 2022-A warrants with an exercise price of $4.37 per share and a five-year term. If all 33,333,336 Series 2022-A warrants were to be exercised in cash at the exercise price of 4.37 per share, the Company would receive additional net proceeds of approximately $145.7 million.

The recent offering has further strengthened the Company’s balance sheet, which is expected to facilitate the financing of the Company’s NZ1 project and to provide financial resources for the Company’s numerous growth opportunities. Gevo is in the process of determining additional plant sites to meet the demand under its existing SAF and hydrocarbon supply ~~them with 75 MGPY~~agreements, and some of ~~SAF for seven years. This agreement replaces~~ the ~~existing agreement~~proceeds are expected to be used to advance those efforts.

Chevron. The letter of intent between Gevo and Chevron signed ~~with Delta~~ in ~~2019~~September of 2021 and scheduled to ~~purchase 10 MGPY~~expire on March 31, 2022, has been extended until August 31, 2022. Chevron and ~~bolsters Delta's commitment~~the Company mutually agreed upon the extension, which allows discussions and negotiations to ~~incorporating SAF into its operations.~~continue.

COVID-19

The COVID-19 pandemic ~~has had an adverse~~continues to impact on global commercial activity, including the global transportation industry and its supply chain, and has contributed to significant volatility in financial markets. It ~~resulted in travel restrictions and extended shutdowns of businesses in various industries including, among others, the airline industry, and significantly reduced overall economic output. It~~ is possible ~~that~~ that the impacts of the COVID-19 pandemic on general economic activity could ~~continue to~~ negatively impact our revenue and operating results for 2022 and beyond. In light of the current and potential future disruption to our business operations and those of its customers, suppliers and other third parties with whom we do business, we considered the impact of the COVID-19 pandemic on our business. The impact of the COVID-19 pandemic on the global transportation industry ~~could continue to~~may result in less demand for our transportation fuel products in the future, which could have a material adverse effect on our business, financial condition, and our prospects for the foreseeable future.

There is also a risk that COVID-19 could have a material adverse impact on the development of our ~~Net-Zero 1 Project,~~NZ1 project, customer demand and cash flow, depending on the extent of our future production activities.

2934

Results of Operations

Comparison of the Three Months Ended ~~March 31,~~June 30, 2022 and 2021 (in thousands):


		Three Months Ended March 31,							Three months Ended June 30,
		2022		2021		Change			2022		2021		Change
Revenue and cost of goods sold	Revenue and cost of goods sold							Revenue and cost of goods sold
Ethanol sales and related products, net	Ethanol sales and related products, net	$	169	$	—	$	169	Ethanol sales and related products, net	$	71	$	—	$	71
Hydrocarbon revenue	Hydrocarbon revenue	63		13		50		Hydrocarbon revenue	18		346		(328)
Grant and other revenue		—		80		(80)
Total revenues	Total revenues	232		93		139		Total revenues	89		346		(257)

Cost of production	Cost of production	3,090		901		2,189		Cost of production	2,640		1,617		1,023
Depreciation and amortization	Depreciation and amortization	1,091		1,093		(2)		Depreciation and amortization	1,088		1,177		(89)
Total cost of goods sold	Total cost of goods sold	4,181		1,994		2,187		Total cost of goods sold	3,728		2,794		934
Gross loss	Gross loss	(3,949)		(1,901)		(2,048)		Gross loss	(3,639)		(2,448)		(1,191)

Operating expenses	Operating expenses							Operating expenses
Research and development expense	Research and development expense	1,192		1,378		(186)		Research and development expense	1,966		1,332		634
Selling, general and administrative expense	Selling, general and administrative expense	9,367		3,814		5,553		Selling, general and administrative expense	9,209		4,846		4,363
Preliminary stage project costs	Preliminary stage project costs	507		2,727		(2,220)		Preliminary stage project costs	314		5,472		(5,158)
Other operations	Other operations	589		—		589		Other operations	601		—		601
Depreciation and amortization	Depreciation and amortization	351		58		293		Depreciation and amortization	386		46		340
Total operating expenses	Total operating expenses	12,006		7,977		$	4,029	Total operating expenses	12,476		16,650		$	(4,174)

Loss from operations	Loss from operations	(15,955)		(9,878)		(6,077)		Loss from operations	(16,115)		(19,098)		2,983

Other income (expense)	Other income (expense)							Other income (expense)
(Loss) gain from change in fair value of derivative warrant liability		—		(53)		53
Gain (loss) from change in fair value of derivative warrant liability								Gain (loss) from change in fair value of derivative warrant liability	—		43		(43)
Interest expense	Interest expense	(2)		(5)		3		Interest expense	(2)		(6)		4
Interest and dividend income	Interest and dividend income	252		31		221		Interest and dividend income	78		—		78
Other income (expense), net	Other income (expense), net	32		(152)		184		Other income (expense), net	2,878		167		2,711

Total other income (expense), net	Total other income (expense), net	282		(179)		461		Total other income (expense), net	2,954		845		2,109

Net loss	Net loss	$	(15,673)	$	(10,057)	$	(5,616)	Net loss	$	(13,161)	$	(18,253)	$	5,092

Revenue. WeDuring the three months ended June 30, 2022, we sold 359 thousand gallons of SAF, isooctane, and isooctene from our Luverne ~~Minnesota development facility f~~Facilityor. Revenue decreased $0.3 million during the three months ended ~~March 31, 2022. Revenue was $0.2 million for~~June 30, 2022, compared to the three months ended ~~March 31, 2022, compared to $0.1 million for the three months ended March 31,~~June 30, 2021, due to the ~~temporary shutdown in 2021 related to~~Luverne Facility being operated for the ~~COVID-19 pandemic.~~Company's development projects on a as needed basis.

Cost of goods sold. Cost of goods ~~sold was $4.2~~increased $1.0 million during the three months ended ~~March 31,~~June 30, 2022, compared ~~with $2.0 million during~~to the three months ended ~~March 31,~~June 30, 2021, primarily due to an increase in direct labor and utility expenses as the Luverne Facility was not fully staffed during the second quarter of ~~$2.2 million.~~2021 due to the COVID-19 pandemic. The majority of our costs are related to the production of SAF, isooctane, and isooctene as we continue to develop and tailor our Luverne Facility demonstration operations to support our focus on advancing technology, testing and optimizing alternative feedstocks, yeast strains, and unit operations as well as partnership development for integrated GHG reductions. Cost of goods sold also includes a ~~$2.9~~$2.1 million ~~loss for a~~ net realizable ~~value~~gain adjustment made to our finished goods and work in process inventory. There were no inventory net realizable ~~losses~~value adjustments recorded during the three months ended ~~March 31,~~June 30, 2021, as the Luverne Facility was temporarily shut down due to the COVID-19 pandemic.

Research and development expense. Research and development expense ~~remained relatively consistent~~increased $0.6 million during the three months ended ~~March 31,~~June 30, 2022, compared ~~with~~to the three months ended ~~March 31, 2021.~~June 30, 2021, primarily due to an increase of laboratory expenses and additional stock-based compensation expense.

3035

Selling, general and administrative expense. Selling, general and administrative expense increased ~~by $5.6~~$4.4 million during the three months ended ~~March 31,~~June 30, 2022, compared ~~with~~to the three months ended ~~March 31,~~June 30, 2021, primarily due ~~primarily~~ to increases in personnel costs related to strategic new hiring, stock-based compensation, and professional ~~fees related to new contracts and higher costs for insurance.~~fees.

Preliminary stage project costs. Preliminary stage project costs are related to our ~~NW Iowa RNG~~Verity and future Net-Zero ~~projects~~Projects and consist primarily of ~~research~~employee expenses and ~~development expense in addition to selling, general and administrative expenses of the projects.~~consulting costs. Preliminary stage project costs decreased ~~by $2.2~~$5.2 million during the three months ended ~~March 31,~~June 30, 2022, compared to the three months ended ~~March 31, 2021. The decrease is mainly due to the fact that~~June 30, 2021, primarily because we began capitalizing our ~~Net-Zero 1~~RNG and NZ1 project costs in ~~Q3 2021, after completing certain front-end engineering studies and determining it was probable that we would build Net-Zero 1. Net-Zero 1 and RNG related costs were expensed in Q1~~ 2021.

Other operations. Other operations ~~costs~~expense increased by $0.6 million during the three months ended ~~March 31,~~June 30, 2022, compared to the three months ended ~~March 31, 2021. During the three months ended March 31, 2022, Other operations costs were~~June 30, 2021, primarily related to unallocated engineering and consulting services.

Depreciation and amortization expense. Depreciation and amortization expense increased $0.3 million during the three months ended ~~March 31,~~June 30, 2022, compared to the three months ended ~~March 31,~~June 30, 2021, primarily due to the amortization of our ~~intangible assets, including patents and exclusivity fees.~~patents.

~~(Loss)~~Gain (loss) from change in fair value derivative warrant liability. We incurred no gain (loss) from the change in the fair value of the derivative warrant liability in the three months ended ~~March 31, 2022; the~~June 30, 2022. The last of the liability warrants expired onin February ~~17,~~ 2022.

Interest expense. There were no ~~material~~significant changes in interest expense during the three months ended ~~March 31,~~June 30, 2022, compared to the three months ended ~~March 31,~~June 30, 2021.

Interest and dividend income. Interest and dividend income increased ~~by $0.2~~$0.1 million ~~for~~during the three months ended ~~March 31,~~June 30, 2022, compared to the three months ended ~~March 31,~~June 30, 2021, primarily due to the interest earned on our investments partially offset by the amortization of the bond premiums.

Other income (expense). Other income (expense) increased $2.7 million during the three months ended ~~March 31,~~June 30, 2022, ~~was $0.3 million, a decrease of $0.2 million~~ compared to the three months ended ~~March 31,~~June 30, 2021, primarily due to our receipt of $2.9 million from the US Department of Agriculture's Biofuel Producer Program to support biofuel producers who faced unexpected losses due to the COVID-19 pandemic. The Biofuel Producer Program grants are not tax-exempt.

Comparison of the Six Months Ended June 30, 2022 and 2021 (in thousands):


	Six Months Ended June 30,
(in thousands)	2022		2021		Change
Revenue and cost of goods sold
Ethanol sales and related products, net	$	240	$	—	$	240
Hydrocarbon revenue	81		359		(278)
Total revenues	321		359		(38)
Cost of production	5,730		2,518		3,212
Depreciation and amortization	2,179		2,270		(91)
Total cost of goods sold	7,909		4,788		3,121
Gross loss	(7,588)		(4,429)		(3,159)
Operating expenses
Research and development expense	3,158		2,710		448
Selling, general and administrative expense	18,576		8,660		9,916
Preliminary stage project costs	821		8,199		(7,378)
Other operations	1,190		—		1,190
Loss (gain) on disposal of assets	—		4,954		(4,954)
Depreciation and amortization	737		104		633
Total operating expenses	24,482		24,627		(145)
Loss from operations	(32,070)		(29,056)		(3,014)
Other income (expense)
Gain (loss) from change in fair value of derivative warrant liability	16		(10)		26
Interest expense	(4)		(11)		7
Interest and dividend income	330		—		330
Gain on forgiveness of SBA loan	—		641		(641)
Other income (expense), net	2,894		126		2,768
Total other income (expense), net	3,236		746		2,490
Net loss	$	(28,834)	$	(28,310)	$	(524)

Revenue. There were no significant changes in revenue during the three months ended June 30, 2022, compared to the three months ended June 30, 2021

Cost of goods sold. Cost of goods sold increased $3.1 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to an increase in direct labor and utility expenses due to the Luverne Facility not being fully staffed until the third quarter of 2021 due to the COVID-19 pandemic. The majority of our costs during the six months ended June 30, 2022, were related to the production of SAF, isooctane, and isooctene as we continue to develop and tailor our Luverne Facility demonstration operations to support our focus on advancing technology, testing and optimizing alternative feedstocks, yeast strains, and unit operations as well as partnership development for integrated GHG reductions. Cost of goods sold also includes a $0.8 million loss for a net realizable value adjustment made to our finished goods and work in process inventory. There were no net realizable losses recorded during the six months ended June 30, 2021, as the Luverne Facility was temporarily shut down due to the COVID-19 pandemic.

Research and development expense. Research and development expense increased $0.4 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to an increase of laboratory expenses and additional stock-based compensation expense.

Selling, general and administrative expense. Selling, general and administrative expense increased $9.9 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to increases in personnel costs related to strategic new hiring, stock-based compensation, and professional fees.

Preliminary stage project costs. Preliminary stage project costs are related to our Verity and future Net-Zero Projects and consist of employee expense and consulting costs. Preliminary stage project costs decreased $7.4 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily because we began capitalizing our RNG and NZ1 project costs in 2021.

Other operations. Other operations expense increased $1.2 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021. Other operations costs were primarily related to unallocated engineering and consulting services.

Depreciation and amortization expense. Depreciation and amortization expense increased $0.6 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to the ~~miscellaneous sale~~amortization of ~~consumable inventory.~~our patents.

Gain (loss) from change in fair value derivative warrant liability. We incurred a minimal change in the fair value of the derivative warrant liability in the six months ended June 30, 2022; the last of the liability warrants expired in February 2022.

Interest expense. There were no significant changes in interest expense during the six months ended June 30, 2022, compared to the six months ended June 30, 2021.

Interest and dividend income. Interest and dividend income increased $0.3 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to the interest earned on our investments partially offset by the amortization of the bond premiums.

Other income (expense). Other income (expense) increased $2.8 million during the six months ended June 30, 2022, compared to the six months ended June 30, 2021, primarily due to our receipt of $2.9 million from the US Department of Agriculture's Biofuel Producer Program to support biofuel producers who faced unexpected losses due to the COVID-19 pandemic. The Biofuel Producer Program grants are not tax-exempt.

Critical Accounting Policies and Estimates

There have been no significant changes to our critical accounting policies since December 31, 2021. For a description of our other critical accounting policies and estimates that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our 2021 Annual Report.

Liquidity and Capital Resources

As of ~~March 31,~~June 30, 2022, we had cash and cash equivalents ~~totaling $44.6~~of $173.0 million, short and long-term restricted cash ~~totaling $86.5~~of $76.2 million and ~~short a~~short-term~~nd long-term~~ marketable securities ~~totaling $298.5~~of $297.6 million. The marketable securities are highly liquid and can be converted to cash when needed for ~~operations.~~operations and construction. We expect to use our cash, cash equivalents, restricted cash and marketable securities for the following purposes: (i) identification, development, acquisition and construction of new production facilities and to plan for expanded production to fulfill existing off-take agreements under the NZ1 project, including the Company's Net-Zero ~~Projects;~~projects; (ii) potential investment in RNG projects; (iii) potential development of the Luverne Facility; (iv) development, acquisition and operation of sustainable alcohol-to-SAF plants to produce SAF alone or with partners; (v) operating activities at the Company's corporate headquarters in Colorado, including research and development work; (vi) exploration of strategic alternatives and additional financing, including project financing; and (vii) future debt service obligations. We believe as a result of our cash and cash equivalents balances, and the performance of our current and expected operations, we will be able to meet our obligations and other potential cash requirements during the next 12 months from the date of this report.

Since our inception in 2005, we have devoted most of our cash resources to the development and commercialization of routes to efficiently produce fuels and chemicals from carbohydrates, such as renewable feedstock, using alcohols

(isobutanol and ~~related products from renewable feedstocks.~~ethanol) as intermediates. We have incurred losses since inception, have a significant accumulated deficit, and expect to incur losses for the foreseeable future. We have financed our operations primarily with proceeds from the issuance of equity, ~~and~~ debt securities, and borrowings under debt ~~facilities and product sales.~~facilities.

The Company's transition to profitability is dependent upon, among other things, the successful development and commercialization of its product candidates, the development, acquisition and construction of ~~additional~~commercial level production facilities to support that Company's off-take agreements, the achievement of a level of revenues adequate to support the Company's cost structure, and the ability to raise capital to finance the development, acquisition, and construction of additional productions facilities.

On January 27, 2022, the Company’s stockholders voted to amend the Certificate of Incorporation to increase the total number of authorized shares of common stock from 250 million shares to 500 million shares. Management intends to fund future operations through additional private and/or public offerings of debt or equity securities. In addition, the Company may seek additional capital, on acceptable terms, through arrangements with strategic partners or from other sources. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.

The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):


		Three Months Ended March 31,
		2022		2021			Six Months Ended June 30,
							2022		2021
Net cash used in operating activities	Net cash used in operating activities	$	(12,460)	$	(7,165)	Net cash used in operating activities	$	(17,114)	$	(19,468)
Net cash from investing activities	Net cash from investing activities	$	7,861	$	(4,630)	Net cash from investing activities	$	(8,350)	$	(436,529)
Net cash provided by financing activities	Net cash provided by financing activities	$	(354)	$	458,780	Net cash provided by financing activities	$	138,565	$	522,853

Operating Activities

Our primary uses of cash from operating activities are personnel-related expenses, research and development-related expenses, including costs incurred under development agreements, costs of licensing of technology, legal-related costs, expenses for the development ~~production~~and commercialization of ~~isobutanol, ethanol~~routes to efficiently produce fuels and ~~related products.~~chemicals from carbohydrates, such as renewable feedstock, using alcohols (isobutanol and ethanol) as intermediates.

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, net cash used for operating activities was ~~$12.5~~$17.1 million compared to ~~$7.2~~$19.5 million for the ~~three~~six months ended ~~March 31, 2021.~~ ~~During the three months ended March 31, 2022, net cash used for operating activities was $12.5 million compared to $7.2 million for the three months ended March 31,~~June 30, 2021. The ~~$5.3~~$2.4 million decrease ~~in operating cash flows~~ was primarily due to increased costs associated with our production of isobutanol and hydrocarbon products for market development, process technology and related process engineering work. In addition, we had increases in personnel expenses to support the growth in business activity, partnership development and Verity ~~Tracking~~ development expenses.

Investing Activities

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, we used ~~$7.9~~$8.4 million in cash for investing activities, of which ~~$71.1~~$169.1 million related to proceeds from sales and maturities of marketable securities, offset by the reinvestment of ~~$31.2~~$131.3 million in marketable securities, and ~~$31.5~~$46.0 million of investments in our capital projects, including ~~$18.3~~$26.3 million in the RNG Project, $15.4 million in the ~~NW Iowa RNG project, $9.6 million in the Net-Zero 1 project,~~NZ1 Project, as well as ~~$3.2~~$4.2 million in development projects at Agri-Energy and Gevo.

We completed the construction of the ~~NW Iowa~~ RNG ~~project~~Project and may invest up to an additional $11.4 million for start-up, improvements, and expansions during the remainder of ~~2022. We currently~~2022 or into 2023. Our preliminary NZ1 Project's forecast of additional capital expenditures ranges from~~plan to spend approximately~~ $100 million ~~for~~to $120 million, which includes engineering, development, long-lead equipment deposits, infrastructure support costs associated with electricity, natural gas, raw water, and wastewater service needs, debt financing costs, and debt pre-close project construction ~~equity investment commitments over the next 12 months for the Net-Zero 1 Project.~~costs.

3239

Financing Activities

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, we ~~used $0.4~~had $138.6 million inof net cash ~~from~~provided by financing activities, ~~which~~ primarily ~~consisted~~due to $139.0 million of ~~$0.2~~proceeds from the issuance of common stock and common stock warrants in the June 2022 Offering, net of issuance costs, partially offset by $0.3 million related to the net settlement of common stock ~~for taxes~~ under ~~our~~ stock plans and $0.1 million of ~~interest on~~payments for finance lease liabilities and certain equipment loans.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes since our disclosure in “Quantitative and Qualitative Disclosures About Market Risk” included in Part II, Item 7A of our 2021 Annual Report.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosures.

During the fiscal period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of ~~March 31,~~June 30, 2022, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the required time periods and are designed to ensure that information required to be disclosed in our reports is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes that occurred during the three months ended ~~March 31,~~June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3340

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we have been and may again become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any litigation, other disputes and regulatory proceedings that we believe to be material and we are not aware of any pending or threatened proceedings against us that we believe could have a material adverse effect on our business, operating results, financial condition or cash flows.

In April 2022, two separate incidents occurred at two of the anaerobic digesters that are part of NW Iowa RNG that resulted in the accidental discharge of very small amounts of water and manure into the environment. The DNR has issued notices of violation in connection with the two discharges.

There is a possibility that the DNR will initiate an enforcement action with respect to the April 2022 discharges described above that could result in a monetary sanction being levied against Gevo for the accidental discharges. We do not believe that any such monetary sanctions would be material.

Item 1A. Risk Factors.

You should carefully consider the risk factors discussed in Part I, Item 1A. “Risk Factors” in our 2021 Annual Report, which could materially affect our business, financial condition, cash flows or future results. There have been no material changes in our risk factors included in our Annual Report. The risk factors in our 2021 Annual Report are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Purchases of equity securities by the issuer:

Period Total Number
of Shares
Purchased Average Price
Paid per Share Total Number
of Shares
Purchased as
Part of Publicly
Announced
Plans or
Programs Maximum
Number of
Shares That
May Yet Be
Purchased
Under the Plans
or Programs
January 1, 2022 - January 31, 2022 — $ — — —
February 1, 2022 - February 28, 2022 — $ — — —
March 1, 2022 - March 31, 2022 (1) 66,348 $ 3.33 — —
Total 66,348 $ 3.33 — —


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs
April 1 - April 30, 2022	11,135	$	4.58	—	—
May 1 - May 30, 2022	1,081	$	4.02	—	—
June 1 - June 30, 2022	2,299	$	3.14	—	—
Total	14,515	$	3.91	—	—

~~(1)~~

Represents shares withheld from employees to cover tax withholding obligations upon the vesting of restricted stock awards. The average prices listed in the above table are averages of the fair market prices at which we valued shares withheld for purposes of calculating the number of shares to be withheld.

Item 3. Defaults Upon Senior Securities.

None.

3441

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

3542

Item 6. Exhibits.

The exhibits listed below are filed or furnished as part of this report.

Exhibit
Number
Description Previously Filed
Filed
Herewith
Form File No. Filing Date Exhibit
3.1
Amended and Restated Certificate of Incorporation of Gevo, Inc.

10-K

001-35073
February 24, 2022 3.1
3.2
Second Amended and Restated Bylaws of Gevo, Inc.

8-K

001-35073
November 24, 2021 3.1
4.1
Form of Gevo, Inc. Common Stock Certificate.

S-1

333-168792
January 19, 2011 4.1
4.3
Form of Series 2020-A Warrant to Purchase Common Stock.
8-K 001-35073 July 8, 2020 4.1
10.1 +
Fuel Sales Agreement, dated March 18, 2022, by and between Gevo, Inc. and British Airways plc.
8-K 001-35073 March 21, 2022 10.1
10.2 +
Fuel Sales Agreement, dated March 16, 2022, by and between Gevo, Inc. and Delta Air Lines, Inc.
8-K 001-35073 March 22, 2022 10.1
31.1
Section 302 Certification of the Principal Executive Officer.

X
31.2
Section 302 Certification of the Principal Financial Officer.

X
32.1
Section 906 Certification of the Principal Executive Officer and Principal Financial Officer.**

**
101.INS Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

X
101.SCH Inline XBRL Taxonomy Extension Schema

X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase

X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase

X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase

X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase

Exhibit

Number

Description

Previously Filed

Filed

Herewith

Form

File No.

Filing Date

Exhibit

3.1

Amended and Restated Certificate of Incorporation of Gevo, Inc.

10-K

001-35073

February 24, 2022

3.1

3.2

Second Amended and Restated Bylaws of Gevo, Inc.

8-K

001-35073

November 24, 2021

3.1

4.1

Form of Gevo, Inc. Common Stock Certificate.

S-1

333-168792

January 19, 2011

4.1

4.2

Form of Series 2020-A Warrant to Purchase Common Stock.

8-K

001-35073

July 8, 2020

4.1

4.3

Form of Series 2022-A Warrant

8-K

001-35073

June 8, 2022

4.1

10.1

Form of Securities Purchase Agreement

8-K

001-35073

June 8, 2022

10.1

10.2+

First Amended and Restated Transaction Confirmation, by and between Gevo NW Iowa RNG, LLC BP Canada Energy Marketing Corp, and BP Products North America Inc.

10.3+

Fuel Sales Agreement, dated July 18, 2022, by and between Gevo, Inc. and American Airlines, Inc.

8-K

001-35073

July 22, 2022

10.1

31.1

Section 302 Certification of the Principal Executive Officer.

31.2

Section 302 Certification of the Principal Financial Officer.

32.1

Section 906 Certification of the Principal Executive Officer and Principal Financial Officer.**

101.INS

Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

3643

Exhibit

Number

Description

Previously Filed

Filed

Herewith

Form

File No.

Filing Date

Exhibit

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)


+			Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is not material and is the type of information that the registrant treats as private or confidential.

**			Furnished herewith.

3744

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Gevo, Inc.

(REGISTRANT)


By:			/s/ Alisher Nurmat
			Alisher Nurmat, CPA Vice President and Controller (Principal Accounting Officer)

Date: ~~May 9,~~August 8, 2022

3845


	March 31, 2022		December 31, 2021

Accounts payable - trade	$	1,399	$	4,868
NW Iowa RNG accrued project costs	2,902		11,000
Accrued employee compensation	3,294		4,678
Net-Zero 1 accrued project costs	2,778		5,010
Other accrued liabilities	3,037		2,732

Total accounts payable and accrued liabilities	$	13,410	$	28,288